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Abstract 
The improvement of in vitro and in vivo models for tissue engineering, 
pharmacology, or metabolic studies, is largely requested. In fact, while in 
vitro models are usually preferred due to their convenience and compatibility 
with the 3Rs, unfortunately they lack biochemical interactions, for instance 
cell-cell cross-talk or important bio-barriers leading to non-physiologically 
relevant results. 
The aim of this thesis is to develop a new in vitro system able to recreate 
the main barrier through ingestion, the intestinal epithelium as well as a 
connected target organs, the vascular endothelium and the liver. The thesis 
is focused on the study of nanoparticle (NP) fate after ingestion, the ability 
of NPs to cross the intestinal barrier and the effects on relevant target 
tissues. In order to achieve this aim simplified models were firstly used so 
that the complexity of the system could be increased stepwise to include 
additional cell types, more complex 3D models of tissues, and more 
sophisticated and specific tests of cellular responses to the presence of 
nanoparticles.  
The system developed is a new body-on-a-plate device able to study the 
physiologically relevant doses that actually reach the systemic circulation 
after intestinal absorption. It has a microfluidic flow which transports 
messaging molecules from cell to cell and stimulates them with a constant 
low shear stress.  
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Hence, the results obtained with this new model were compared with data 
generated in conventional static cell cultures in order to validate the system 
and gain a better insight on the systemic effects of NP toxicity. 
Besides the study of the toxicity of nanoparticles of industrial and 
environmental interest, this thesis demonstrates the importance of 
advanced in vitro testing, pointing out the differences in results from 
standard simple cultures with respect to those obtained from more relevant 
physiological model. 
  
  
8 
 
Section I 
Introduction 
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Chapter 1 
In vitro models for Toxicology Testing 
 
1. TOXICOLOGY 
 
Toxicology is the study of the adverse effects of chemical, physical or 
biological agents on people, animals, and the environment. Many studies 
are required to ensure the safety of medicines, household and gardening 
chemicals, and industrial and natural chemicals to which everybody is 
continuously exposed. 
Toxicologists know that no substance is risk-free. Paracelsus, in the 16th 
century, summarized this concept in the sentence “All things are poison, 
and nothing is without poison; only the dose permits something not to be 
poisonous", or more commonly, "the dose makes the poison".  That is to 
say, substances considered toxic are harmless in small doses, and 
conversely an ordinarily harmless substance can be deadly if over-
consumed.  
For this reason, toxicology research is important for ensuring the health of 
humans, animals, and their environments. This research is intended to 
identify harmful effects of potential new products and to provide 
understanding of the mechanisms by which chemical substances cause 
injury, in order to use this information in the treatment of poisonings. 
Toxicology represents an area of science of growing importance, largely as 
a consequence of the rapid increase in environmental and safety legislation. 
A further driver of toxicology is the continuing growth of the industrial sector 
which develops a greater number of new materials and compounds. 
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All organisms are composed of chemicals, and chemical reactions power all 
life processes. When a substance is introduced into a body, it can interact in 
many places and effects upon one process can cause unexpected 
consequences in others.  
The use of animals in this kind of experiments is fundamental because such 
complexity cannot be duplicated in normal cell culture or in non-living 
systems. For example, toxicity can be influenced by the speed with which 
the substance enters the system, how the metabolic organs change it and 
how it is taken up by and interacts with various body tissues. 
 
Fig. 1: Schematic diagram explaining how a chemical can change into another thanks to 
internal metabolism. Adapted from [1]. 
 
Moreover, because "the dose makes the poison" at the level of the 
individual organ, we need to be able to analyze not only how a chemical 
acts, but the relationship between the dose given to the animal and the dose 
delivered to the different organs and tissues in the body. Studies in whole 
animals are required to ensure the proper use of beneficial chemicals such 
as medicines, because the tissue or organ receiving the beneficial effect 
might be harmed if exposures are greater than needed. In many cases, 
laboratory tools simply cannot duplicate these complicated phenomena [2]. 
Ultimately, animal testing is the best method to detect effects such as 
cancer and birth defects, even if it sometimes is difficult to identify the right 
model to test as demonstrated by the Thalidomide case whose 
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teratogenicity was found only occasionally in the huge set of different 
animals and species tested [3]. 
 
2. THE ANIMAL TESTING DEBATE 
 
The ethical questions raised by performing experiments on animals are 
subject to much debate, and viewpoints have shifted significantly over the 
20th century [4].The case for animal experiments is that they will produce 
such great benefits for humanity that it is morally acceptable to harm a few 
animals. The equivalent case against is that the level of suffering and the 
number of animals involved are both so high that the benefits to humanity 
don't provide moral justification.  
Animal welfare, and animal rights organizations (such as PETA -People for 
the Ethical Treatment of Animals- and BUAV -British Union for the Abolition 
of Vivisection-) question the legitimacy of animal testing, arguing that it is 
cruel, poor scientific practice, poorly regulated, that medical progress is 
being held back by misleading animal models, that some of the tests are 
outdated, that it cannot reliably predict effects in humans, that the costs 
outweigh the benefits, or that animals have an intrinsic right not to be used 
for experimentation.[3] 
Heavy pressure from these associations leads to a high interest of scientist 
and governments to address the animal testing issue. Moreover, as 
technology has advanced, new ways to stop animal testing have come into 
the picture. In 1959, Russel and Burch published The Principles of Humane 
Experimental Technique in which “the 3 R’s principles” were proposed to 
encourage scientist reducing the impact of research on animals. 
“The 3 R’s” stand for reduce, refine and replace and means: 
Reduction: 
• Reducing the number of animals used in experiments by:  
o Improving experimental techniques 
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o Improving techniques of data analysis 
o Sharing information with other researchers 
Refinement: 
• Refining the experiment or the way the animals are cared for so 
as to reduce their suffering by:  
o Using less invasive techniques 
o Better medical care 
o Better living conditions 
Replacement: 
• Replacing experiments on animals with alternative techniques 
such as:  
o Experimenting on cell cultures instead of whole animals 
o Using computer models 
o Studying human volunteers 
o Using epidemiological studies 
In November 2008 the European Union put forward proposals to revise the 
directive of 1986 for the protection of animals used in scientific experiments 
in line with the three Rs principle of replacing, reducing and refining the use 
of animals in experiments. The proposals have three aims: 
• to considerably improve the welfare of animals used in scientific 
procedures 
• to ensure fair competition for industry 
• to boost research activities in the European Union [5]. 
Now EU rules for animal experimentation are more restrictive, requiring that 
experiments where animals are used be subject to authorization and state 
that alternatives to testing on animals must be used when available and that 
the number of animals used in projects be reduced to a minimum [6].  
The Commission and industry have set up the European Partnership for 
Alternative Approaches to Animal testing (EPAA) whose aim is to promote 
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the development of new ‘3R’ methods as alternative approaches to the use 
of animals in safety assessment. 
Another thing to take in account about the reducing of animal testing issue 
is that concerning the Cosmetics industry. The 7th amendment to the 
Cosmetics Directive (76/768/EEC) foresees a testing and marketing ban on 
cosmetics tested on animals. The directive on animal testing (86/609/EEC) 
does not amend the rules provided for in other pieces of EU legislation. The 
sales ban means not only that cosmetics’ testing is mostly ended in the 
European Union but also that even products tested elsewhere cannot be 
sold there. 
The testing ban on cosmetics has been in application since 2009 when 
testing was prohibited irrespective of alternatives to animal testing being 
available. The marketing ban applies unconditionally to all human health 
effects with the exception of three toxicological effects such as repeated-
dose toxicity, reproductive toxicity and toxicokinetics. The year 2013 is 
foreseen as the deadline for a ban on these specific health effects. 
The interest for non-animal methods is clearly really high. 
 
3. IN VITRO MODELS 
 
In vitro models are the obvious solution to the replacement of animal testing. 
In vitro refers to studies in experimental biology that are conducted using 
components of an organism that have been isolated from their usual 
biological context in order to permit a more detailed or more convenient 
analysis than can be done with whole organisms. Common examples of in 
vitro experiments include:  
• cells derived from multicellular organisms (cell culture or tissue 
culture) 
• subcellular components (e.g. mitochondria or ribosomes) 
• cellular or subcellular extracts (e.g. wheat germ or reticulocyte 
extracts) 
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• purified molecules in the test tube (proteins, DNA, or RNA, either 
individually or in combination) [4]. 
In vitro studies allow scientists to isolate specific cells, bacteria, and viruses 
and study them without the complexity of a whole organism. This permits an 
enormous level of simplification of the system under study, so that the 
investigator can focus on a small number of components [7]. For example, 
the knowledge of the mechanism by which a protein target recognizes and 
binds to a receptor is the result of the extensive use of in vitro work that 
means isolate the proteins, identify the cells and genes that produce them, 
study the physical properties of their interaction with molecules, and identify 
how those interactions lead to cellular signals that activate other 
components of the response pathway. 
In toxicology, in vitro testing methods are employed primarily to identify 
potentially hazardous chemicals and/or to confirm the lack of certain toxic 
properties in the early stages of the development of potentially useful new 
substances such as therapeutic drugs, agricultural chemicals and direct 
food additives 
In vitro toxicity testing: 
• provides rapid and effective means of screening and ranking 
chemicals in food or environment for a number of toxicology 
endpoint 
• allows the understanding of the mechanism by which a toxic lead 
effects at both the cellular and molecular level, and of both causal 
and adaptive responses 
• is essential for bridging between experimental animal and human, 
and addressing the correct species choice 
• provides well defined and simplified system for studying structure-
activity relationship 
• provides a means for identification of key molecular events that are 
involved in toxicity, enabling the development of effective 
biomarkers of effect 
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• enables detailed analysis of the toxicological consequences of 
genetic variation within the population 
• enables assessment of cell-specific (e.g. liver, cardiac, kidney, 
neural, immune system) and, where possible, tissue-specific (e.g. 
embryo) effects; 
• allows establishing the nature of concentration-effect relationships 
and the existence of effect-specific thresholds in cells from different 
species and different tissues [8]. 
 
 
 
Fig. 2:  Progressive activation of toxicity pathways from perturbation of initial target low dose, 
through activation of stress controlling pathways (medium dose), to overtly toxic responses 
(high dose). Biologic responses from exposure results in perturbation of biologic pathways, 
accumulation and high dose lead to toxicity and disease. Adapted from [9]. 
 
As already mentioned, in vitro assays for xenobiotic toxicity are recently 
carefully considered by key government agencies (e.g. EPA; NIEHS/NTP; 
FDA) due to the social movement to reduce the use of animals in research, 
and a desire to better assess human risks.  
Most toxicologists believe that in vitro toxicity testing methods can be a 
useful, time and cost-effective supplement to toxicology studies in living 
animals. However, it is generally accepted that the available in vitro tests 
are not presently adequate to entirely replace animal toxicology tests. 
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For example, the hazardous properties of chemicals cannot be sufficiently 
determined using currently available in vitro testing methods, as noted in a 
report published by the European Centre for the Validation of Alternative 
methods (ECVAM). Until prediction of metabolism can be more reliably 
accomplished through computational toxicology and in vitro testing, some 
degree of highly targeted testing using whole animals may be needed to 
identify metabolites and to assist in developing pharmacokinetic models for 
the distribution of test compounds and their metabolites in humans [9].  
Relying solely on vitro methods can underestimate the potentially hazardous 
properties of chemicals that could be harmful to humans and the 
environment. 
 
In vitro models 
 
Advantages Disadvantages 
2-D cell culture model 
(conventional monolayer 
model) 
Easy and convenient to 
maintain, increased viability  
Loss of organ-specific cell-to 
cell interactions and 
differentiated functions 
 
2-D co-culture model Interactions between multiple 
cell types  
 
Cell-cell competition, 
complicated and conflicting 
culture requirements 
3-D cell culture model 
(hydrogels, multicellular 
spheroids, and multilayer 
cell culture) 
Well-defined geometry, co-
cultivation of multiple cell 
types, mimics the in vivo  
situation very closely, and 3-
D scaffold for mechanical 
stability 
Poor viability, diffusion and 
action of chemicals altered, 
multicellular resistance, and 
expensive 
Tissue slice/Grafting model 3-D representation of cellular 
environment, preserve cell-
to-cell & cell-to-matrix 
environment, realistic 
preclinical model, and 
Viability is limited, 
morphological evaluation 
alters with the slice, difficult 
to reproduce, and limited 
availability for human models 
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preserve the functional and 
morphological heterogeneity 
Micro-scale cell culture 
model 
(microfluidic cell culture 
system) 
Mimics the in vivo situation 
very closely, controlled 
microenvironment, allow 
reproduction of 
biotransformation in vitro, 
short reaction times, 
portability, low cost, and 
small consumption of 
reagents and cells 
Complex fluidic connection 
and flow control required, 
expensive detection and 
analysis system, and 
formation of air bubble 
 
Tab.1: Commonly used in vitro models in toxicology: advantages and disadvantages. 
Adapted from [10]. 
 
The most commonly used in vitro model is represented by cells in culture. 
Normally, these cells are cells lines, then derived from tumors or 
immortalized and are therefore transformed. Another in vitro approach is to 
use primary cells that can be kept in culture only for a certain time. Both cell 
cultures can result in loss of differentiated properties, different metabolic 
components and modified functionality. The weakness of those in vitro tests 
result from the fact that the cells are isolated from their natural environment 
and are no longer integrated into an ordered tissue and organ topology.  
Metabolic conversions of xenobiotics would be studied using subcellular 
fractions in vitro approach. These systems usually favor only the specific 
biotransformation step, depending on the type of isolation procedure, on the 
cofactors added, on the source of tissue, and on the expression level of the 
involved enzymes. However, the balance of metabolic activation and 
inactivation requires a highly ordered interplay of many enzymes and 
cofactors in most cases. 
Also, it is difficult to study effects on integrated and at the same time 
diffusely organized systems like the neuro, immuno and endocrino systems. 
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Hence, to study effects on these organ systems in vitro is not an easy task 
[8]
. 
 
4. ADVANCED IN VITRO MODELS AND BODY ON A CHIP MODEL 
 
In this scenario, new tools and technology for in vitro toxicology testing are 
highly required by industries and governments as an alternative to animal 
testing but also as an improvement of available cell culture systems.  
In 2004, the U.S. Environmental Protection Agency (EPA) and the U.S. 
National Institute of Environmental Health Sciences (NIEHS) asked the U.S. 
National Research Council (NRC) to conduct a review and a long-term 
strategic plan to update and advance toxicity testing. The NRC Committee 
on Toxicity Testing and Assessment of Environmental Agents produced two 
reports. The final report outlined four design criteria, which should guide the 
development of a new toxicity-testing paradigm: 
1. achieving broad coverage of chemicals, chemical mixtures, 
outcomes, and life stages; 
2. diminishing the cost and time required for toxicity testing;  
3. developing a better scientific basis for assessing human health 
effects of environmental chemicals, including knowledge of modes of 
action;  
4. minimizing the use of animals in toxicity testing [11] . 
The new paradigm has to integrate with the widely used four-stage risk 
assessment framework originally proposed by the NRC in 1983 in the so-
called Red Book: hazard identification, dose-response assessment, 
exposure assessment, and risk characterization. 
The newest techniques, such as in silico models, -omics technologies and 
high-throughput screens, have been considered in this advanced in vitro 
toxicology. 
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Tab. 2: New in vitro toxicity testing tools and their application in the risk assessment. Adapted 
from [11]. 
 
An approach to overcome in vitro test limits is to perform a more realistic 
model that mimics animal and human response accurately, increasing 
Tool 
 
Application 
High-throughput 
screens 
Efficiently identify critical toxicity pathway perturbations across a range 
of doses and molecular and cellular targets 
Stem cell biology Develop in vitro toxicity pathway assays using human cells produced 
from directed stem cell differentiation 
Functional genomics Identify the structure of cellular circuits involved in toxicity pathway 
responses to assist computational dose-response modeling 
Bioinformatics Interpret complex multivariable data from HTS and genomic assays in 
relation to target identification and effects of sustained perturbations on 
organs and tissues 
Systems biology Organize information from multiple cellular response pathways to 
understand integrated cellular and tissue responses 
Computational 
systems biology 
Describe dose-response relationships based on perturbations on cell 
circuitry underlying toxicity pathway responses giving rise to thresholds, 
dose-dependent transitions, and other dose-related biological behavior 
Physiologically based 
pharmacokinetic 
models 
Identify human exposure situations likely to provide tissue 
concentrations equivalent to in vitro activation of toxicity pathways 
Structure-activity 
relationships 
Predict toxicological responses and metabolic pathways based on the 
chemical properties of environmental agents and comparison to other 
active structures 
Biomarkers Establish biomarkers of biological change representing critical toxicity 
pathway perturbations 
Molecular and genetic 
epidemiology 
 
Incorporates molecular markers of exposure and biological change into 
population-based studies; integrates the knowledge of the human 
genome into epidemiological studies to understand genetic susceptibility 
and gene-environment interaction in disease causation 
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control over cell–cell and soluble cues typical of in vivo cell environments. 
Cells sense most extracellular signals (including proteins, peptides and 
carbohydrates) via transmembrane receptors that activate complex 
biochemical cascades which regulate cell physiology. Moreover, cells are 
sensitive to the presence of neighboring cells of similar or different type and 
often make long-lasting mechanical and biochemical connections to them 
[12], [13]
. 
The first step in this direction is to combine microfabrication of 3D 
extracellular matrix (ECM) structures and microfluidic networks that 
transport soluble factors such as nutrients and oxygen. In this way 
mechanical strain, through shear, in the physiological range is also created 
[14]
.  
Recent advances in using microfabrication with cell culture technology 
resulted in the rise of a new research field often referred to as cells-on-chip 
technology, which has allowed researchers to have precise control over in 
vitro biological systems with microscale resolution [15]. 
Body on a chip models are physiologically more relevant than single or co-
culture in vitro models, stimulating the multi-tissue interactions and crossing-
talk given by fluid flow condition.  
Those systems also achieve one of the aspects of new desired tools that is 
the high-throughput screening of several compounds in a cheaper and less 
time consuming manner. 
Microfabrication techniques allow the creation of devices with structures of 
sizes relevant to biological systems such as cell sizes (on the order of 10 
µm) and the sizes of human blood vessels with spacing between capillaries 
on the order of 100 to 200 µm. The result is a more physiological growth 
environment with relevant shear stress, liquid-to-cell ratios, and 
physiological fluid residence times in tissue compartments. Devices that are 
design with regard to the structure of the human body in scale are known as 
micro Cell Culture Analog device (µCCA). 
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Sung and Shuler, in 2009, demonstrated the importance of in vitro 
microfluidic mimics device in drug testing [16]; their system, contained liver 
cells (HepG2/C3A), colon cancer cells (HCT-116), and myeloblasts 
(Kasumi-1) was used to test Tegafur, an oral prodrug of the cancer drug 5-
fluorouracil (5-FU), with better bioavailability than that of 5-FU.  
The µCCA was able to reproduce the metabolism of Tegafur, in the liver cell 
compartment, in order to let 5-FU travelled through the microfluidic 
connections to the cancer cell compartment and caused its action as a 
decrease in cell viability.  
Viravaidya and collaborators developed a µCCA with liver and lung cells to 
assess toxicity of chemical as naphthalene [17]. Naphthalene is known to 
cause oxidative stress with subsequent glutathione (GSH, anti-oxidative 
molecule) depletion assuming due to its metabolite naphthalene epoxide; in 
this study it was demonstrated that the observed toxicity on lung cells is 
caused by naphthoquinone rather than naphthalene epoxide being the half-
life of naphthalene epoxide in aqueous medium 3.6 min, and the residence 
time in the other tissue/debubbler compartment is approximately 50 min, so 
the epoxide cannot reach the lung cells to cause the oxidative stress. 
 
Other technologies can be useful in development of more physiological 
devices.  
Mathematical models can be used to foresee complex processes, for 
example the absorption, distribution, metabolism, and elimination (ADME) of 
a new compound. ADME processes are important because determine the 
concentration-time profiles in the bloodstream and in the tissues of organs. 
Pharmacokinetic (PK) and pharmacodynamic (PD) models and more 
complex physiologically based pharmacokinetic (PBPK) models can predict 
the time-dependent pharmacological effects of a drug and increase the 
predictability of human response leading to higher success rates in clinical 
trials. 
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PBPK models and µCCAs can be used in combination to inform each other. 
In the development of multicompartment devices, representations of the 
human body such as PBPK models can be used to guide the device design 
with regard to the arrangement of chambers and fluidic channel 
connections. In this way, furthermore, the resulting systems are physical 
representations of PBPK models and the reactions are that described by the 
equations of the model. Because PBPK models rely on the input of already 
known mechanisms, conversely, data obtained with these systems may be 
used to test and refine mechanistic hypotheses and to amplify the model 
with new pathways and reactions to reach a more complete system. The 
µCCA and PBPK model can be used in an iterative manner to test 
modifications in the proposed mechanism and to validate each others. 
 
Next step in advanced in vitro models is the implementation of body-on-a-
chip devices with analytical and detection technology. The ‘micro-total-
analysis-system’ (µTAS) framework seeks to create microsystems 
incorporating several steps of an assay into a single system [14]. Integrated 
microfluidic devices perform rapid and reproducible measurements on small 
sample volumes while high sensitivity of analytical methodologies is 
required due to the small physical dimensions of culture systems inherently 
contain small numbers of cells, leading to mass-limited quantities of analyte 
molecules. Optical and electrical techniques have found extensive 
application in these devices owing to their ready compatibility with 
microfluidic formats and relative ease of operation. Such systems can 
provide near-real-time analysis. Indicator testing compound such as 
autofluorescent substrate can be added to the device to evaluate change in 
the metabolite fluorescence or absorption in order to evaluate the ability of 
the cells to perform that metabolic reaction.  
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Fig. 3:  Micro cell culture analog (µCCA) connected to an in situ fluorescence optical 
detection system (ISFODS). (a) The system consists of a syringe µCCA chips and the 
ISFODS. (b) Medium-containing substrate is perfused into a µCCA, above the liver cells, and 
the fluorescent product from P450 enzyme metabolism is detected at the detection chamber, 
where the detection of fluorescent signal is made. Adapted from [18]. 
 
The integration of ultraviolet-visible absorption spectroscopy with 
microfluidic cell culture chips has been used, for example, to study 
acetaminophen metabolism and cytotoxicity [19].  
Many electrical measurement methods such as amperometry with 
enzymatic bioelectrodes and cellular impedance can be integrated into 
µCCA devices [20]. Electrical impedance measurements are a particularly 
attractive option for determining cell viability in microfluidic cell culture 
devices because they are real time, label free, and non-invasive [21-23]. 
 
Another advanced technique in cells culture is the use of scaffolds. More 
authentic cellular behaviour is facilitated by making a three-dimensional 
structure that can be a simple hydrogel encapsulation of cells or mixtures of 
cell types [24] or preformed scaffolds that may represent a high level of 
authenticity, particularly for autocrine-like compounds. These systems also 
increase the concentration of cell in the chamber helping the analysis of 
metabolites and secreted molecules. Although most work with µCCAs has 
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utilized two-dimensional cell cultures, it has been demonstrated that a 3D 
culture enhance the cells vitality and growth [25]. The mechano-physical 
features of the scaffolds can favor cells adhesion and survival and lead to 
biological signals released [26]. 
 
Finally as noticed by Esch et al. in their review about body on a chip devices 
more useful devices should developed and included barrier tissue analogs. 
Barrier tissues such as the epithelium of the gastrointestinal (GI) tract, the 
lung epithelium, the skin, and the blood-brain barrier can significantly reduce 
the bioavailability of drugs that are taken up orally, through inhalation, or 
through application to the skin, leading to reducted doses to the target 
organs.  
A study of Mahler et al. improve the µCCA device  with a co-culture of 
intestinal epithelial cells (CaCo-2 cell) and HT-29 goblet-like cells so that the 
epithelium was covered with mucous [27]. Proof of concept experiments 
showed that acetaminophen (one of the most widely used analgesic and 
antipyretic drugs) passes through the epithelial layer where is firstly 
metabolized and then is further metabolized by liver cells, resulting in liver 
cell toxicity in a dose-dependent manner. The presence of the GI-tract 
barrier reduced liver cell death because acetaminophen diffused slowly 
across the mucous-covered CaCo-2/HT-29 cell layer, and, in addition, 
intestinal cells also converted some of the drug into nontoxic metabolites.  
 
A future direction in advanced in vitro testing is individualized health care 
[28]
. 
Since the level of enzymes and other metabolites can differ from person to 
person, everyone responds differently to drugs. Small tissue sample could 
be taken from a patient (biopsy) and tested for the efficacy of a mixture of 
drugs or for a range of different biological tests. 
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New advanced in vitro technologies are less expensive and ethically less 
questionable than experimenting with animals, moreover they allow a larger 
experimental space to be explored. The microfluidic format and the 
presence of possibility to study multiple-cell type in combination afford the 
devices several advantages compared to others in vitro drug screening 
models. A big challenge is recreating authentic cell behavior on the 
microfluidic platform and developing sensors that can monitor the 
physiology of cells within three-dimensional tissue constructs. These 
devices can be used as a preliminary screening to determine whether to 
invest effort and resources in a particular drug testing or biochemical 
pathway. 
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Chapter 2 
Nanotoxicology: an emerging issue 
 
Nanoparticles (NPs) are generally defined as engineered structures 
possessing at least one dimension sized from 1 to 100 nm. The science 
which studies and manipulates those nano-objects is nanotechnology, 
which consists essentially in a set of techniques that allows creating and 
using materials and devices at a very small scale.  
Although nanoparticles are generally considered an invention of modern 
science, they actually have a very long history. Probably the earliest use 
being in glazes for early dynasty Chinese porcelain. A Roman cup, called 
the Lycurgus cup, used nanosized gold cluster to create different colors 
depending on whether it was illuminated from front or the back, obviously 
the cause of this effect was not known to those who exploited it [29]. 
Even these days, pottery from the Middle Ages and Renaissance often 
retain a distinct gold or copper colored metallic glitter. The luster was 
caused by a metallic film applied to the transparent surface of a glazing. The 
luster originated within the film itself, which contained silver and copper NPs 
dispersed homogeneously in the glassy matrix of the ceramic glaze. These 
nanoparticles were created by the artisans by adding copper and silver salts 
and oxides together with vinegar, ochre and clay, on the surface of 
previously-glazed pottery [3].  
The first description, in scientific terms, of the optical properties of 
nanometer-scale metals was provided by Faraday in his classic 1857 paper 
[30]
. In 1908, Turner points out that: "It is well known that when thin leaves of 
gold or silver are mounted upon glass and heated to a temperature which is 
well below a red heat, a remarkable change of properties takes place, 
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whereby the continuity of the metallic film is destroyed. The result is that 
white light is now freely transmitted, reflection is correspondingly 
diminished, while the electrical resistivity is enormously increased" [31]. 
Nowadays, the ability to see nano-sized materials has opened up a world of 
possibilities in a variety of industries and scientific endeavors. 
 
 
Fig. 4: Picture represents “The Scale of Things”, it provides a comparison of various objects 
to help understanding exactly how small a nanometer is. From objects that can be seen 
by human eye to objects about a nanometer or less in size, such as the ATP molecule 
used in humans to store energy from food. (Designed by the Office of Basic Energy 
Sciences (BES) for the U.S. Department of Energy using U.S.). Reproduced with 
permission from [32]. 
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1. NANOPARTICLES: PROPERTIES AND APPLICATIONS 
 
The large interest for NPs is due to the fact that the transition from 
microparticles to nanoparticles can lead to a number of changes in physical, 
chemical, electrical, optical, mechanical and magnetic properties. NPs are 
effectively a bridge between bulk materials and atomic or molecular 
structures. A bulk material should have constant physical properties 
regardless of its size, but at the nano-scale size-dependent properties are 
often observed. Thus, two of the major factors in this are the increase in the 
ratio of surface-area-to-volume, and size of the particle moving into the 
realm where quantum effects predominate. The increase in the surface-
area-to-volume ratio, which is a gradual progression as the particle gets 
smaller, leads to an increasing dominance of the behavior of atoms on the 
surface of particle over that of those in the interior of the particle. For bulk 
materials larger than one micrometer, the percentage of atoms at the 
surface is insignificant in relation to the number of atoms in the bulk of the 
material. The interesting and sometimes unexpected properties of 
nanoparticles are therefore largely due to the large surface area of the 
material, which dominates the contributions made by the small bulk of the 
material. 
High surface area is a critical factor in the performance of such technologies 
as fuel cells and batteries (see below). The large surface area of NPs also 
results in a lot of interactions between the intermixed materials in 
nanocomposites, leading to special properties such as increased strength 
and/or increased chemical/heat resistance [33]. The high surface area 
provides, also, a tremendous driving force for diffusion, especially at 
elevated temperatures. Sintering can take place at lower temperatures, over 
shorter time scales than for larger particles. Moreover, NPs have been 
found to impart some extra properties to various day to day products. For 
example the presence of titanium dioxide nanoparticles imparts what we call 
the self-cleaning effect, and the size being nano-range, the particles cannot 
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be observed [34]. In fact, the dimension below the critical wavelength of light 
renders them transparent, a property which makes them very useful for 
applications in packaging, cosmetics and coating (see below). Zinc oxide 
particles have been found to have superior UV blocking properties 
compared to its bulk substitute. This is one of the reasons why it is often 
used in the preparation of sunscreen lotions [35], and is completely 
photostable [36]. 
Clay nanoparticles when incorporated into polymer matrices increase 
reinforcement, leading to stronger plastics, verifiable by a higher glass 
transition temperature and other mechanical property tests. These 
nanoparticles are hard, and impart their properties to the polymer (plastic) 
[37]
. Moreover, perfectly-formed silicon nanospheres, with diameters of 
between 40 and 100 nanometers, are not just harder than silicon but among 
the hardest materials known, failing between sapphire and diamond [38]. NPs 
are currently made out of a very wide variety of materials such as titanium, 
zinc, aluminum, iron oxide and silicate NPs. Those new materials are used, 
or being evaluated for use, with different applications in several fields. The 
list below introduces some of those fields of use: 
• Electronic: to increase the capability of electronics devices, for 
example display screens, reducing their weight and power 
consumption; or increasing the density of memory chips and 
reducing the size of transistors used in integrated circuits [39].  
• Energy: to improve the efficiency of energy generation or develop 
new methods to generate energy. Stronger and lower weight blades 
are made possible by the use of nanotube-filled epoxy, increasing 
the amount of electricity generated by each windmill [40]. Companies 
(Bloo Solar, Solamer Energy, Nanosolar, etc.) have developed 
nanotech solar cells that can be manufactured at significantly lower 
cost than conventional solar cells. 
• Space: Mavroidis and co-workers from Northeastern University in 
collaboration with NASA Institute of Advanced Concepts Design 
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developed two macro-scale devices with important space application 
that will be using bio-nanocomponent assemblies to build bio-nano 
robots in spacesuits [41], [42]. 
• Environment: improve the environment, cleaning up existing 
pollution and improving manufacturing methods to reduce the 
generation of new pollution. Researchers at NASA Kennedy Space 
Center have shown that iron NPs can be effective in cleaning up 
organic solvents that are polluting groundwater [43], [44]. 
• Consumer Products: nano has already found its way into lots of 
products of everyday use, from clothing to tennis racquets. Skin care 
products use NPs to deliver vitamins deeper into the skin; 
sunscreens also use NPs to block UV rays without leaving white 
residue on the skin. Lithium ion batteries use NP based electrodes 
powering plug in electric cars. Fishing rods use silica NPs to fill 
spaces between carbon fibers, strengthening the rod without 
increasing the weight. A nanoporous material called ThermaBlok® 
Aerogel Insulation is an excellent insulator, needing about one third 
the thickness compare to conventional insulation [45]. Nanoparticles 
have also been attached to textile fibers in order to create smart and 
functional clothing [46]. 
• Chemical Sensors: nanotechnology can enable sensors to detect 
very small amounts of chemical vapors. Various types of detecting 
elements, such as carbon nanotubes, zinc oxide nanowires or 
palladium nanoparticles can be used in nanotechnology-based 
sensors. These detecting elements change their electrical 
characteristics, such as resistance or capacitance, when they absorb 
a gas molecule [47]. 
• Medicine: the main application of nanotechnology in medicine 
currently being developed involves employing NPs for drugs delivery 
[48], [49], [50]
. Particles are engineered so that they are attracted to 
diseased cells, allowing direct treatment of those cells (e.g. cancer 
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cells [51], [52]). This technique reduces damage to healthy cells in the 
body and allows for earlier detection of disease. In therapy fullerene 
NPs (also known as buckyballs) may be used to trap free radicals 
generated during an allergic reaction and block the inflammation that 
results from an allergic reaction [53]. Z-Medica is producing a medical 
gauze that uses aluminosilicate NPs that can quickly reduce 
bleeding in trauma patients by absorbing water, causing blood in a 
wound to clot quickly [54], [55]. Nanotechnology is also used in 
diagnostic and imaging techniques [56], [57]: iron oxide NPs can be 
coated with a peptide that binds to a cancer tumor in order to 
enhance, once the NPs are attached to the tumor, the images from 
the Magnetic Resonance Imagining scan thanks to the magnetic 
property of the iron oxide [58], [59]. NPs can attach to proteins or other 
molecules, allowing detection of disease indicators in a lab sample 
at a very early stage. Finally, NPs are involved in anti-microbial 
techniques as nanocrystalline silver [60] or nanocapsules containing 
antibiotics [59]. 
• Food: Companies are developing nanomaterials that will make a 
difference not only in the taste of food, but also in food safety, and 
the health benefits that food delivers. The Sharper Image developed 
FresherLongerTM Miracle Food Storage Containers which keep foods 
fresher longer than conventional containers thanks to the 
antimicrobial silver nanoparticles in the polypropylene material that 
reduce the growth of microorganisms. Researchers are using silicate 
nanoparticles to provide a barrier to gasses like oxygen, or moisture 
in a plastic film used for packaging reducing the possibly of food 
spoiling or drying out [61]. Zinc oxide nanoparticles can be 
incorporated into plastic packaging to block UV rays and provide 
anti-bacterial protection, while improving the strength and stability of 
the plastic film [62]. Nanosensors are being developed detect bacteria 
and other contaminates, such as salmonella, at a packaging plant. 
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This point-of-packaging testing has the potential to dramatically 
reduce the chance of contaminated food reaching grocery store 
shelves. 
 
All the applications and examples given are only a small part of the products 
and projects on emerging nanotechnologies; a longer list is available on the 
web site www.nanotechproject.org. 
 
2. NANOTOXICOLOGY 
 
Nanotechnology offers society the promise of major benefits, and the use of 
nanotech in consumer and industrial sectors is expected to increase 
significantly in the future. In parallel however, because NPs have unique 
properties different from conventional materials, concerns about safety have 
been raised. The same properties of nanostructured materials that make 
them so attractive for applications could potentially lead to unforeseen 
health or environmental hazards [63]. 
In fact, the high surface to volume ratio can make the particles very reactive 
or catalytic [64]. Moreover the ability of NPs to pass through cell membranes 
in organisms, and their interactions with biological systems make them of 
high potential hazard [65]. 
In Europe and in the USA, governments, non-governmental organizations, 
and others have expressed concern that, while the field of nanotechnology 
and the number of consumer products incorporating nanomaterials increase 
dramatically, in many cases, the safety of these materials has not been 
demonstrated and there are still a large number of unanswered questions. 
For example, little is known about the relationship between nanoparticles 
(NPs) physicochemical characteristics and their ability to cross biological 
barriers and to enter the general circulation, their fate within the body 
(toxico-kinetics), their subsequent toxic impact, or the ability of our bodies to 
defend against such toxic impact. 
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Fears over the possible dangers of some nanotechnologies may be 
exaggerated, but they are not necessarily unfounded. Recent studies 
examining the toxicity of engineered nanomaterials in cell cultures and 
animals have shown that size, surface area, surface chemistry, solubility 
and possibly shape all play a role in determining the potential for engineered 
nanomaterials to cause harm [66]. 
First increased surface area enhances contact with their surrounding 
exposing catalytic or other active sites on the particle surface [67], in some 
cases inducing the formation of reactive oxygen species (ROS) [68]. 
Second, due to their small size, NPs are retained in many cells and organs 
to a larger extent at the intracellular more than at the extracellular level due 
to solubilization or degradation that takes place inside cells. Toxic effects 
have also been demonstrated to depend on the uptake mechanism (see 
below) [69], presumably due to differences in fate, for example, being stored 
in intracellular vesicles or secreted. 
Another propriety to take in account is the shape of NPs that can play a 
crucial role in determining responses. Geometric effects have been 
highlighted by the example of high toxic needle-shaped carbon nanotubes, 
which impale entire cells [70], [71]. 
 
Physico-chemical NP properties of relevance for toxicology 
 
Size (airborne, hydrodynamic) 
Size distribution 
Shape  
Agglomeration/aggregation 
Surface properties  
Area (porosity) 
Charge 
Reactivity 
Chemistry (coating, contaminants) 
 
Properties can change: 
 
• With method of production, 
preparation process, storage 
 
• When introduced into 
physiological, media, organism 
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Defects 
Solubility (lipid, aqueous, in vivo) 
Cristallinity 
 
Tab. 3: List of some physico-chemical properties of NPs that impact on their biological ⁄ 
toxicological activity. Adapted from [72]. 
 
Rivera Gil and collaborators provided the main points that are important for 
nanotoxicological  screening approaches [73], pre-testing criteria that should 
be kept in mind include: 
(1) the need for defined and well-characterized NPs as model systems 
(2) knowledge of NP properties and potential for exposure during all stages 
of their life cycle 
(3) the need for knowledge about biokinetics 
(4) the need for validated in vitro models that are predictive of outcomes 
following in vivo exposures 
(5) the need for evidence that in vitro outcomes are NP-specific via 
appropriate benchmarking (i.e., does a solute produce the same response? 
Do larger particles of the same composition produce the same response?) 
(6) the need for ranking new NPs against well-validated benchmark NPs. 
Moreover the concepts of dosimetry, dose metrics, exposure assessment, 
hazard identification, and risk characterization need still to be assessed. 
The challenge for both health and environmental protection is to ensure that 
as nanomaterials are developed and use, any unintended consequences of 
exposures to humans are prevented or minimised. In addition, knowledge 
concerning how best to apply nanotechnology to detect, monitor, prevent 
and control is needed. 
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3. NANOPARTICLES EXPOSURE AND BIOKINETIC 
 
Numerous applications of nanomaterials lead to many possible routes 
through which synthetic and free nanoparticles can get into the human 
body. 
With the expected increased intentional (e.g., in the field of medical 
diagnostics) and unintentional (e.g., in occupational settings and chemical 
waste streams) exposures to NPs nanotoxicology has now become a critical 
element in safety assessments of nanomaterials. In the beginning interest in 
the potential toxicity of very small particles starts from studies of workers 
exposed to metal fumes [74] and inhalation studies with ultrafine particles [75]. 
As matter of fact the portal of entry for nano-objects firstly and mostly 
studied is the pulmonary tract.  
 
 
Fig. 5: A schematic overview of biokinetics of NPs.  The arrows connect the routes, in 
dashed arrows the potential routes. Adapted from [66]. 
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Inhaled particles smaller than 2.5 µm have access to the alveolar structures 
of the deep lung and may induce inflammation. Most of the particles that 
deposit into the lung are removed by mucociliary transport or, at alveoli 
level, through macrophage disposal. It was shown that high doses of 
nanoscale particles are, also capable of crossing the thin air–blood barrier 
to transmigrate into the blood [76]. 
Another inhaled route going directly to the brain is the uptake via olfactory 
nerve, here the particles can reach the brain, even if in a really small 
amount, and by pass the blood-brain barrier [77]. 
The healthy skin instead represents an effective barrier against many NPs. 
The uptake of nanoparticles, especially of the non-lipophilic type involved in 
cosmetics and in sunscreen applications, is hampered by the anatomic 
structure of the human skin. The EU FP6 project NANODERM (NanoDerm, 
2008) results showed that TiO2 deposited only in the corneocyte layers of 
the stratum corneum or in the hair follicles but is not detected in the deeper 
regions of the skin; although it was found by another group that very small 
particles (<10 nm) are capable of penetrating through to the epidermis or 
dermis [78]. Particle surface coatings or functionalization which are often 
used to prevent agglomeration, may strongly influence the penetration [79]. 
The corneal layer of stressed or diseased skin is more permeable to all 
kinds of particles and must be regarded independently [80]. 
Since the use of nano-materials is continuously highlighted in food and 
packaging, a route of increasing importance is the gastrointestinal tract. The 
nutrients, as well as everything orally taken, are absorbed by the small and 
large intestines by the intestinal epithelium and can be distributed in the 
body via the bloodstream. 98% of the nanoparticles administered orally to 
the test animals were excreted in the feces, whereas the rest was 
eliminated via urine, indicating some uptake into the blood circulation. In the 
same study, but using NPs intravenously administered approximately 80% 
of the material was found to have accumulated in the liver after one week 
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[66]
. As matter of fact, injected administration route has to be considered 
since nanomaterials are really promising in diagnostic and therapeutic 
medical applications [81]. 
Going to the cellular level, several uptake mechanisms for NPs have been 
proposed. In contrast with large particles (> 500 nm) which will be 
exclusively taken up by phagocytosis, NPs may use other different 
translocation routes into the cells. NPs transport can use receptor-binding 
mechanisms [82], [83], diffusion through the plasma membranes, as adhesive 
interactions [84], [85] and any vesicle transport pathway for particles with 
diameters below 100 nm [86], [87]. 
 
Fig. 6: Proposed uptake mechanisms for nanoparticles with different size. Adapted from [88]. 
 
The subsequent effects observed are influenced by the different uptake 
mechanisms: in the case of uptake by vesicular processes, particles are 
sheathed by membranes (for example, caveolae). Free transport through 
the membrane, however, would be assumed to be more critical, as it allows 
particles to achieve direct contact with the plasma proteins and with other 
molecules of the cell. The uptake of nano-particles may well have fatal 
consequences for the cell if the material consists of, for example, an 
incompatible metal and/or is removed owing to physiological conditions. 
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Moreover, NPs that do not dissolve but remain stable for a long time 
(biopersistent) or accumulate in cells may become “active” in another way 
while obeying the surface principle: as there are considerably more atoms 
available on the particle surfaces, they can interact with the environment 
much more efficiently. Finally, for biological systems coming into contact 
with such objects, the materials constituting the nanofractions are also 
relevant even with uniform shapes and sizes [89], [90]. 
Size, shape, surface, and composition can significantly cause biological 
effects and must be considered separately for each material to evaluate its 
potential toxicity.  
 
4. NANOPARTICLES TESTING AND RISK ASSESSMENT 
 
New properties and behavior of NPs with respect to bulk materials leads to 
the need for a systematic risk research as information about safety and 
potential hazards is required. Toxicology tests and the resulting database 
would provide information for material safety data sheets for NPs as well as 
a basis for potential NP risk assessments and risk management. 
Toxicity assays will identify the potential hazard by establishing dose-
response relationships or stress and inflammatory responses. However, 
because a risk of adverse effects associated with NPs is a function of 
hazard and exposure, the generally accepted approach is to incorporate 
both components into a risk assessment paradigm, consisting of Hazard 
Identification, Hazard Characterization, Exposure Assessment and Risk 
Characterization [91] so that appropriate risk management decisions can be 
made. 
Whereas first investigations concerning the toxicity of NPs were based on in 
vivo experiments (i.e., inhalation studies, etc.), due to the huge amount of a 
large variety of different NPs it is desirable to develop and validate simple 
non in vivo assays in order to reduce and avoid extensive testing using 
laboratory animals. In vitro studies enable the identification of conceptual 
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models for interactions of NPs with cells [73]. An important issue to take in 
account within in vitro models is the interference of the NPs with well-
established toxicity assays in order to avoid confounding or even conflicting 
data. Each test should be characterized in advance considering the 
presence of NPs, moreover it is recommended to perform two different tests 
for each biological end point to exclude cross-reactions [88]. 
 
Cytotoxicity 
assay 
Detection principle NP 
interference 
Altered 
readout 
Particle 
studied 
Cell viability 
MTT Colorimetric 
detection of 
mitochondrial 
activity 
Adsorption of 
substrate 
Reduced 
indication of 
cell viability 
Carbon 
nanoparticles 
LDH Colorimetric 
detection of LDH 
release 
Inhibition of 
LDH enzyme 
Reduced 
indication of 
necrosis 
Trace metal-
containing 
nanoparticles 
Annexin V Fluorimetric 
detection of 
Phosphatidylserine 
exposure (apoptosis 
marker) 
Ca 2+ depletion Reduced 
indication of 
apoptosis 
Chitosan 
nanoparticles 
Propidium 
Iodide 
Staining of DNA 
(necrosis marker) 
Dye adsorption Reduced 
indication of 
necrosis 
Carbon 
nanoparticles 
Neutral red Colorimetric 
detection of intact 
lysosomes 
Dye adsorption Reduced 
indication of 
cell viability 
Carbon 
nanoparticles 
Caspase Fluorimetric 
detection of 
Caspase-3 activity 
(apoptosis marker) 
Inhibition of 
Caspase-3 
enzyme 
Reduced 
indication of 
apoptosis 
Trace metal-
containing 
nanoparticles, 
especially Zn2+ 
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Stress response 
DFC Fluorimetric 
detection of ROS 
production 
Fluorescence 
quenching 
Reduced 
indication of 
oxidative stress 
Carbon 
nanoparticles 
Inflammatory response 
ELISA Colorimetric 
detection of cytokine 
secretion 
Dye adsorption Reduced 
indication of 
cytokine 
concentration 
Metal oxide 
nanoparticles 
Tab. 4: Nanoparticles interference with cytotoxicity assay. Adapted from [92]. 
 
In vitro high-dose toxicology and mechanistic studies should be viewed as 
proof-of-principle studies, though, that ultimately require validation in vivo. A 
major issue that needs to be carefully considered is the relevancy of the 
doses applied in vitro for predicting in vivo outcomes. At very high doses 
assays can certainly identify a NP as hazardous but how realistic is the 
study for in vivo exposure conditions?  
Therefore, it is desirable to develop and validate simple non in vivo assays 
for the purpose of predicting in vivo responses. 
In parallel, efforts should be made to obtain data on exposure levels 
occurring for workers at NP manufacturing sites despite best occupational 
hygiene conditions, as well as for anticipated consumer exposures to nano 
enabled products [72]. 
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 Fig. 7: The evaluation process of toxicity of NPs. In the diagram are shown the in vitro-
in vivo relationship and its extrapolation to humans. Adapted from [88].  
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Chapter 3 
Bioreactor design and improvement for 
investigating absorption, 
biotransformation & biodistribution 
 
1. BIOREACTOR: MCmB  
 
The request of more physiological tests that do not involve animals was 
underlined in chapter 1. Given the concerns regarding animal testing many 
groups have developed systems that are more representative of human 
physiology (as described in paragraph 4, chapter 1). 
Our group at the Interdepartmental Research Center “E.Piaggio”, developed 
a “system on a plate” modular MultiCompartmental Bioreactor (MCmB) 
array [93] commercialized as Quasi-Vivo® (by Kirkstall Ltd). Its main 
advantage is its size: with no need to change multiwell plate/petri dish 
culture protocols. The microscale dimensions that make body-on-a-chip 
devices (described in paragraph 4, chapter 1) so attractive lead also to the 
need of translating experimental methods to be feasible in the micro-range. 
The MCmB offers the possibility to use the same protocols as multiwell 
plates improving them with mechanical, flow and biochemical stimuli, or 
cross-talk by adding other cell types so as to recreate the physiological 
environment. It was designed as an easy-to-assemble modular lego-type 
device according to finite element methods and allometric scaling in order to 
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have low shear stress, high nutrient turnover, and physiologically relevant 
cell numbers and fluid residence times. Many cues should be controlled in 
vitro using engineering and design as shown in figure 8. 
 
Fig. 8: A representation of the more important biochemical, physio-chemical and mechano-
structural cues presented in the cellular microenvironment and the parameters that can be 
controlled. Adapted from [94]. 
 
The level of cross-talk is likely to depend strongly on dynamic stimuli such 
as flow and concentration gradients. The flow rate and volume will 
determine the residence and passage times of molecules and oxygen, as 
well as the shear stress on the cells. The goal of dynamic culture device 
design is the balance between high oxygen mass transfer and low wall 
shear stress to cells. Shear stress is given by a fluid moving along a solid 
boundary, this tangential flow constantly stimulates cells [95] by a low velocity 
convective motion but in contrast most type of cells cannot support high 
levels of shear which compromises their function.  
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The MCmB is fabricated in PDMS (polydimethylsiloxane), a biocompatible 
elastomer. The modular chamber is similar in size to that of a 24 well plate 
with a volume of 2 mL. The choice to design a modular device is justified by 
the possibility to allow any tissue or organ model to be simulated and 
performed simply by connecting the chambers in a desired configuration. 
The bioreactor unit is composed of two self-sealing (male-female joint) 
parts, of which top piece has smart design that allows bubbles (one of the 
biggest problem in microfluidic device) to be conveyed to the outlet tube. 
Varying the flow rate it is possible to set oxygen and nutrient residence time 
and low shear stress of the order of 10-5 Pa at the bottom of the chamber 
where cells are housed. 
 
 
Fig. 9: Pictures of MCmB showing the size and the shape (A). In the right, bioreactor is 
shown within his closure system (B) 
 
MCmB is well characterized in Mazzei et al. [93] and has been already tested 
using different high throughput multi compartmental bioreactor experiments 
[94-101]
. 
Hepatocytes were firstly used to test the MCmB because they are the 
difficult cells to culture for their rapid loss of phenotypic expression in-vitro 
and because of their sensitivity to oxygen concentration, with high metabolic 
demands. 
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The high importance of flow rate has been shown, with a decrease in 
viability below 180 µL/min, due to lower oxygen concentration, and above 
500 µL/min as result of too high shear stress. Albumin production, analyzed 
as marker of function, confirmed the vitality of cells as the albumin 
concentration under flow condition was higher with respect to controls till 
500 µL/min [93]. 
In Guzzardi et al. a study on metabolic regulation in dynamic culture 
conditions in the MCmB was performed and compared with static models. In 
this work cross talk between hepatocytes and adipocytes was explored. 
Significant differences in metabolic and functional profiles between static 
and dynamic settings, and in the mono- versus the connected cultures were 
found [96]. 
In Vinci et al. it was shown that the combination of 3-D scaffolds and 
dynamic flow conditions enhances hepatocyte culture with an increase in 
cell density compared with monolayer controls and a three-fold increase of 
metabolic function in dynamic culture compared with static monolayer 
cultures [97]. 
In a second work, it was demonstrated that the presence of flow significantly 
modifies cellular metabolism of hepatocytes, adipocytes and endothelial 
cells [98]. Hepatocytes, endothelial cells and adipocytes were connected 
together each in a MCmB chamber to investigate metabolic cross-talk 
between them in regulating glucose and lipid metabolism [99]. 
Another work from the same author used the MCmB for primary human 
hepatocyte culture, showing that medium flow stimulates the expression and 
activity of detoxification genes [95]. Those results were confirmed by Vozzi et 
al. [100] who detected diclofenac (arylacetic non‐steroidal anti‐inflammatory 
drug -NSAID-) toxicity in the MCmB system at concentrations significantly 
lower than conventional hepatocyte cultures, similar to what has been 
observed in-vivo. 
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2. ALLOMETRY 
 
A modular device allows the possibility of designing experiments according 
different models. In our work we choose to develop a system according to 
allometric rules. 
Allometry is the science of scaling and deals with changes in body size and 
relationships amongst different parameters and processes in all organisms 
as a function of body mass M. The basic allometric equation can be used to 
correlate physiological variables between organisms of different sizes. 
Y = a • Mb 
Y is the physiological parameter (for example time, length, metabolism) and 
M is the mass of the organism, a is a proportionality factor and b is the 
allometric exponent [94]. 
In simpler words, allometry is used to calculate the biological dimensions 
and parameters of in vitro systems to ensure that the most important 
features (cell numbers, cell ratios, flow rates) with respect to those of the 
human body. 
This scaling model ensures that the same relationships between cells and 
organs in the human body are going to be maintained even in the bioreactor 
environment. Varying the number of bioreactors it is possible to vary cell 
surface, cell number, cell volume relationships to get closer to the 
physiological body relationship. 
The simplest scaling model considers the cell ratios. It was estimated that 
ratio between endothelial weight and hepatic tissue weight in the abdominal 
region is 1:10 [101], so in order to reproduce this relationship 10 fold more 
hepatocytes with respect with HUVECs should be used. Translated to the 
MCmB this means one bioreactor each cell type, since the HUVECs have a 
surface area almost 10 fold more respect with hepatocytes so in the same 
confluent surface there will be 10 fold less cells. 
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Sbrana and Ahluwalia [94] studied allometric scaling within the MCmB 
considering different models such as biotransformation, gas exchange, skin 
and intestinal adsorption, glucose metabolism, excretion and nutrient 
transport using exchange surface areas and metabolism rather than cell 
numbers. Their results are summarized in the table 5.  
 
MCmB physiological 
model 
Cells Modules 
(chambers) 
Relationship 
Biotransformation 
 
Hepatocytes 1 liver  
Gas Exchange and 
Biotransformation 
Hepatocytes, Lung 
epithelial cells 
4 lung epithelia 
(confluent layer), 1 
liver 
Lung mass, b=1 
(800 g) 
Lung area, b=2/3  
(80 m2) 
Absorption and 
Biotransformation 
Hepatocytes, Skin 
epithelia 
12 liver, 1 skin 
epithelia (confluent 
layer) 
Skin mass, b=0.87,  
(4-8 kg) 
Skin area, b=2/3  
(1.8 m2) 
Nutrient absorption and 
Biotransformation 
Hepatocytes, 
Intestinal epithelial 
cells 
1 liver, 9 intestinal 
epithelia (confluent 
layer) 
Intestinal bed, b=2/3 
(200 m2) 
Biotransformation and 
Nutrient transport 
Hepatocytes, 
Endothelial cells 
4 liver, 1 
endothelial cell 
(confluent layer) 
Capillary bed, 
b=11/12 
Total capillary bed 
area=500 m2 
Biotransformation, 
Nutrient transport and 
Nutrient absorption 
Hepatocytes, 
Endothelial cells, 
Intestinal epithelial 
cells 
4 liver, 1 
endothelial cell, 32 
intestinal epithelia 
 
  
Tab. 5: An example of allometric-based MCmB configurations for some physiological models, 
considering surface area and metabolic scaling. Adapted from [94]. 
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The relationship between endothelial cells and hepatocytes was tested 
experimentally [101] as will be described in chapter 4. 
 
3. INLIVETOX BIOREACTOR SYSTEM 
 
The MCmB was the starting point to develop a dedicated device for the 
InLiveTox project.  The aim of the device was to simulate the processes of 
intestinal absorption, endothelial biodistribution and hepatic 
biotransformation using 3 tissues. The final system, ILT, therefore consisted 
of 2 MCmB chambers with HUVECs and hepatocytes respectively and also 
included a specially designed chamber with a semi-permeable membrane 
(figures 10 and 11). 
 
 
Fig. 10: ILT system diagram showing the two circuit and the cell types involved 
 
The first circuit represents the gastrointestinal tract, only intestinal epithelial 
cells are housed in this circuit; a membrane with intestinal cells on it 
separates the upper from the lower circuit which is composed of the lower 
part of intestinal bioreactor connected to two bioreactors housing endothelial 
and hepatocyte each. 
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The intestinal bioreactor was designed in a two step way in order to have a 
first version (ILT 1) to test and a second improved version (ILT 2) which 
would solve all any problems with the first design version. Only ILT2 version 
was used for the experiments described in this thesis. Target cell 
bioreactors are two unmodified MCmB modules (named in the project and 
this thesis ILT 0).  
 
3.1. ILT 2 intestinal bioreactor 
The ILT 2 intestinal bioreactor consists of a microfabricated membrane, a 
membrane holder and a silicon chamber designed on the basis of ILT 0 
bioreactor. Special ILT 2 closures were fabricated in order to allow the insert 
of electrodes that take contact with the electrical surface of the membrane. 
This electrical contact is needed for the continuous measurement of the 
TEER (Trans-epithelial electrical resistance) which gives, constantly, the 
value of the integrity of the epithelial layer. ILT 2 bioreactor is shown in fig. 
11. 
 
Fig. 11: ILT 2 bioreactor: a membrane into its holder (A), holder into the chamber (B), the 
electrode sticks (C) and the complete intestinal bioreactor with closure and electrodes 
inserted (D). 
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Two bubble traps were added before each ILT2 circuit (upper and lower) to 
avoid bubbles that can lead to inconstant measurement. 
 
3.2. ILT complete system 
The complete ILT system consists of 1 ILT 2 intestinal bioreactor (with a 
membrane in the holder) and 2 ILT 0s connected after the lower part of ILT 
2. Moreover 2 bubble traps were added before each ILT 2 inlet tube to avoid 
bubble formation that interferes with the flow measurement. 
 
 
Fig. 12: Scheme of complete three tissue ILT system 
 
The final system looks as in figure 13. 
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Fig. 13: The final ILT system: complete assembled system (A) and in the incubator 
connected to the pump (B). 
 
A 
B 
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Section II 
Experimental design, materials and 
methods  
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Chapter 4 
Experimental design  
 
The main part of this thesis was carried out within the European Union FP7 
InLiveTox project. Its focus was on the setup of the ILT system both from 
the technical and biological testing side. It also involved the study of the 
toxicity of some nanoparticles of industrial and environmental interest. NP 
toxicity was assessed on HUVEC in static conditions, while both HUVEC 
and C3A were tested in dynamic conditions using an optimized allometric 
configuration. Finally, after the “healthy” baseline was established, the 
complete three tissue ILT system was tested with two types of NP and 
positive control, to assess the system’s performance.  
 
In detail, the experimental plan was divided into 6 steps to achieve the 
objectives outlined in the abstract. 
 
1. ESTABLISHMENT OF NPs TESTING ON HUVEC STATIC 
CULTURE  
 
Firstly NP toxicity was evaluated in static conditions to establish a dose-
response curve for each particle using standard in vitro methods. Moreover 
we can compare the results to those observed in ILT system. 
HUVEC (as well all the other cell types) were tested with each nanoparticle 
(Polystyrene-FITC 50nm, Polystyrene-FITC 200nm, Ag, TiO2, Au 15nm and 
Au 80 nm) in order to establish lethal and sub-lethal effects within a range of 
concentrations. 
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It was decided to perform different assays, some of them evaluating the 
same function at different levels or with two different methods. The aim was 
to reduce mismatching and false positive/negative outputs due to NP 
interference.  
All the assays performed are listed in the table below (Tab. 6): 
 
FUCTION ASSAY OTHER ASSAY 
Viability Metabolic activity (Alamar 
Blue) 
Membrane integrity  (LDH 
assay) 
Oxidative stress GSH assay 
 
 
Apoptosis Fas Ligand Bead Assay 
 
 
Inflammation 
 
Cytokine Bead Assay  
vWF marker mRNA expression 
 
Immunostaining 
 
Tab. 6: Assays chosen for NP toxicity evaluation 
 
Each assay was checked for the NP interference in absence of cells and 
where necessary the value was subtracted from the sample data. 
 
2. IDENTIFICATION OF COMMON DYNAMIC CULTURE 
CONDITIONS  
 
To perform a dynamic multiple cell type culture, all cell types need to be 
connected to each other by a flow of medium. Standard culture medium for 
the 3 cell types are 3 different ones, so a common medium was required 
and testing of different media was performed. 
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HUVEC, C3A and CaCo-2 cells were tested in different media and the best 
one was chosen as a common medium for the ILT system (named ILT 
medium). Moreover, both HUVEC and C3A were separately tested in ILT 
medium at different flow rates in order to establish a range of flow feasible 
for the cells in the lower circuit. The testing concerned viability evaluation as 
well as some marker analysis. 
All the technical parameters such as volume, flow rate, position of the pump 
with respect to the bioreactors as well as protocols for seeding cells onto 
coverslips and their handling were established. 
 
3. ALLOMETRIC SCALING 
 
A remarkable aspect of the system is the modular design so that each 
model can be assessed independently and then together. Allometric scaling 
enables a physiologically relevant model to be property designed. Two 
different scaling models were tested; one was studied considering the cell 
number ratio between cells, so proportional scaling, and the other based on 
metabolic rates. According to table 5 in chapter 3, the nutrient absorption-
nutrient transport-biotransformation model, should have 32 intestinal 
epithelia, 1 endothelial and 4 liver bioreactors. However, because of the limit 
in membrane availability, 32 intestinal epithelia bioreactors could not be 
employed. Therefore we used a simpler model with only 1 intestinal 
bioreactor with increased flow circulation to increase passage through the 
membrane. 
The allometric scaling models were then used for studying the relationship 
between HUVEC and C3A in the body. It was decided to experimentally 
study the simplest scaling model that considers the cell ratios (named cell 
number scaling model or CNSM), already mentioned in chapter 3 paragraph 
2, and the model of biotransformation and nutrient transport described in 
table 5, chapter 3 (named surface and metabolic scaling model or SMSM). 
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Briefly a system with 1 HUVEC and 1 C3A bioreactors represents the CNS 
model (ratio between endothelial weight and hepatic tissue weight in the 
abdominal region 1:10) while 1 HUVEC connected to 4 C3A represents the 
SMS model (see tab. 5, chapter 3). Both the models were tested for viability 
and markers of functionality; moreover the cross-talk between the two 
tissues was studied and discussed. The best allometric scaling, leading to 
more physiological result, was chosen as a “lower circuit” for the ILT 
system. 
 
4. NP DYNAMIC TESTING WITH SINGLE TISSUE CONFIGURATION 
 
Having set up all the parameters for the dynamic system and established 
the dose-response curve in static conditions, it is possible to start checking 
whether the toxicity of those particle changes under flow conditions. The 
most toxic nanoparticle, Ag, was chosen for this test. HUVEC and C3A were 
firstly checked respectively for negative and positive baselines (healthy and 
dead cells) in the dynamic set up. Then some concentrations of Ag NP (a 
range from 5 µg/mL to 100 µg/mL) were analyzed. 
Those results enabled the assessment of NP toxicity under flow conditions 
in the absence of cell cross-talk. 
 
5. EVALUATION OF ILT SYSTEM BASELINE  
 
In this step a baseline for functional markers and viability of the 3 cell types 
in the connected abdomen-mimic system, the ILT complete system, was 
established. All the assays were checked for sensitivity of measuring 
markers in ILT volumes and baseline values were defined. Moreover, a 
“dead cell” baseline using TRITON X-100 (non-ionic surfactant able to 
permeabilize and destroy cell membranes) in order to have even the high 
toxic marker values was also performed. 
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6. NPs TESTING IN ILT SYSTEM  
 
In the final part of the thesis the complete system was tested with 
nanoparticles. Polystyrene-FITC NP was firstly chosen to measure the NP 
passage across the intact epithelial barrier. Then again, the most toxic NP, 
Ag, was assayed in order to have detectable end-points. The results were 
compared with the other in vitro testing models to determine the 
physiological relevance of cell response in the ILT system.   
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Chapter 5 
Materials and methods 
 
1. CELL CULTURE 
 
Eagle’s Minimum Essential Medium (EMEM), Dulbecco Modified Eagle’s 
Medium High Glucose (DMEM-HG), Penicillin/Streptomycin/Amphotericin B, 
L-Glutamine was purchased from Lonza Bioscience (Basel, Switzerland). 
Fetal bovine serum (FBS) was purchased from PAA (Pasching, Austria); all 
other reagents were purchased from Sigma-Aldrich (St. Louis, USA) if not 
otherwise specified. 
 
1.1. HUVEC extraction and culture 
HUVEC (Human Umbilical Vein Endothelial Cell) were extracted using a 
modified protocol collagenase solution treatment from Baudin et al. [102]. Two 
donated umbilical cords were sufficient for all the experiments.  
The medium for culturing HUVEC was EMEM supplemented with 10% FBS, 
1% Penicillin/Streptomycin/Amphotericin B, 2 mM L-Glutamine; 1% non-
essential amino acids 100X; 1% MEM vitamins solution; 10 µg/mL 
Endothelial Cell Growth Supplement (ECGS), 10 ng/mL Human Epidermal 
Growth Factor (hEGF); 3 ng/mL basic Fibroblast Growth Factor (bFGF); 1 
µg/mL Hydrocortisone, 10 µg/mL Heparin Sodium Salt (named ILT 
medium). The endothelial cells were routinely trypsinized and used between 
passage 3 and 8.  
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HUVEC were seeded 24 h before the experiment, on a surface (well plate, 
or plastic coverslip (NUNC, Denmark)) coated with 1% Gelatin from porcine 
skin with a concentration of 20,000 cells/cm2. 
 
1.2. C3A culture 
Human hepatoma-derived cell line C3A (ATCC Culture, USA) were cultured 
in EMEM with 10% FBS, 1%Penicillin/Streptomycin/Amphotericin B, 1% L 
Glutamine 200 mM; 1% non-essential amino acids 100X and 1% MEM 
vitamins solution (named complete EMEM). C3A were seeded in a 300,000 
cells/cm2 concentration. Only if seeded on glass coverslip a collagen 
coating is added: 200 µL of 0,2 mg/mL of  type I collagen was pipetted and 
let cross link for about 30 min at 37°C. Collagen was prepared by extracting 
acid-soluble collagen from rat tail tendons [103]. 
 
1.3. CaCo-2 culture 
Human epithelial colorectal adenocarcinoma cells, CaCo-2 (ATCC Culture, 
USA) were cultured in DMEM High-Glucose medium with 10% FBS, 
1%Penicillin/Streptomycin, 1% non-essential amino acids 100X (named 
complete DMEM). Cells were seeded in a 60,000 cells/cm2 concentration. 
When CaCo-2 are seeded on ILT membranes, 21 days are needed for 
differentiated and confluent layer cells before using for the experiment. 
ILT membranes were fabricated by CSEM (Neuchatel, Switzerland) with a 
structure of silicon-nitride (SiN) wafer with 1 µm porous membrane. Each 
membrane was cleaned and activated with Piranha water (sulfuric acid 
H2SO4 (96%), hydrogen peroxide H2O2 (30%) @ 50°C) treatment. Before 
seeding CaCo-2, membranes were housed in ILT membrane holder with 
biological-compatible tape which insures the electrodes holes remain dry 
and sterile during the culture. 
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1.4. Dynamic cell culture  
Dynamic experiments were carried out in ILT 0 bioreactor system 
(described in chapter 3) when endothelial cells and/or hepatocytes were 
used. A flow rate of 100 µL/min was chosen with 15 mL volume of ILT 
medium (if not differently specified). If epithelial cells were used, the 
experiment was carried out in the ILT 2 bioreactor system (described in 
paragraph 3.1, chapter 3). In this case the upper circuit flow rate was set at 
200 µL/min while the lower at 100 µL/min and the volume was 15 mL of ILT 
medium each circuit. Bioreactors can be connected to each other in order to 
have a more complex system for different kinds of experiment.  
 
1.4.1. Assembling of ILT 0  
Coverslips from HUVEC and/or C3A culture were moved to the bottom of 
the ILT chamber. Each bottom part of the chamber was filled with 500 µL of 
media in order to avoid drying of cells during assembly of the system. The 
rest of the volume was added to the mixing bottle. In general the total circuit 
volume is 2 mL per chamber plus 3 -5 mL for the mixing chamber and 
tubing. However it may vary if bubble traps or long term cultures are used. 
Chambers were closed and connected to the system and let run with the 
pump (Ismatech IPC-4, Zurich, Switzerland) into a 37°C/5% CO2 incubator 
for the experimental time.  
  
1.4.2. Assembling of ILT 2  
The membrane with fully differentiated cells was taken from the culture well; 
the external part of the holder was dried with sterile gauze. Tape was taken 
off from the holes with tweezers and the membrane was inserted between 
the two parts of the ILT 2 bioreactor. Then the bioreactor was closed and 
electrodes were pushed till electrical contact was made with the membrane. 
ILT 2 was connected to each circuit system (upper and lower circuit) and 
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filled with the medium previously added to each mixing bottle. The complete 
system with the pump (Ismatech IPC-4, Zurich, Switzerland) was placed in 
the 37°C/5% CO2 incubator for the desired time.  
 
2. NANOPARTICLES 
 
Nanoparticles tested are shown in table 7. 
Tab. 7: List of the tested nanoparticles and their sources 
 
For each NP, aliquots of 2 mL solution were prepared with a concentration 
of 1 mg/mL in ILT medium. Stock solution was sonicated in a water bath 
(Bandelin electronic, Berlin, Germany) before each use. 
 
3. EXPERIMENTAL PROTOCOLS 
 
Each experiment was performed under sterile conditions and was run at 
least in triplicate. 
 
 
 
Nanoparticle Source 
 
Polystyrene-FITC Fluoresbrite® 
Microparticles 50 nm (PS 50) 
Polystyrene-FITC Fluoresbrite® 
Microparticles 200 nm (PS 200) 
Polysciences Inc. (Germany) 
Ag NM 300  Ras GmbH 
TiO2 rutile-anatase, thermal, 7 nm Hombikat UV100 
Phosphine-Au NP 15 nm (Au 15) 
Phosphine-Au NP 80 nm (Au 80) 
Kind gifted from Dr W.G. Kreyling 
(Helmholtz Zentrum Munich) 
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3.1. Establishment of NPs testing on HUVEC static culture 
6,200 HUVEC cells in 200 µL were seeded in gelatin coated 96 multiwell 
plates 24 h before the experiment. Then medium was replaced with 200 µL 
of fresh medium containing different concentrations of NP as in the scheme 
below (Table 8), for each NP type. 
 
NP 
 
Conc (µg/cm2) 
 
 
 
HUVEC 
 
Polystyrene-FITC 50 nm 
Polystyrene-FITC 200 nm 
Ag NM 300 
TiO2 
Ph-Au NP 15 nm 
Ph-Au NP 80 nm 
625 
312,5 
156,3 
78,1 
39,1 
19,5 
9,8 
4,9 
2,4 
1,2 
 
Tab. 8: List of concentrations used for NP tests 
 
After 24 h medium and cells were analyzed. 
Control samples were seeded and analyzed in the same condition and time 
of treated samples. They were untreated HUVEC (negative control) and 
Triton™ X-100 treated HUVEC (positive control). For each particle 
concentration the interaction with the assay was also tested in the absence 
of cells in order to avoid false negative or positive result due to particles 
interference (as discussed in chapter 2, paragraph 4). 
 
3.2. Identification of common culture conditions 
Three different media were tested in order to choose an optimum common 
medium:  
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• ILT medium (as described above) 
• ECGM medium plus supplement kit (Promega, Madison, USA) 
• Complete EMEM (as described above) 
Cells were seeded in a 24-well plate at the same concentration in each 
medium and analyzed over 3 days for viability.  
Then, HUVEC and C3A cells were seeded on coverslips to be analyzed in 
single-cell dynamic conditions at different flow rates in the chosen medium 
to determine the best range of flow rates. As controls, the same type and 
number of coverslips were placed in a Petri dish with the same amount of 
medium as the dynamic experiment (8 mL of ILT medium).  
Morphology was observed for HUVEC and metabolic markers such as 
albumin, urea and glucose were analyzed for C3A. 
 
3.3. Allometric Scaling 
HUVEC (25 000 cells/coverslip) and C3A (250 000 cells/coverslip) were 
seeded on coverslips as described in paragraph 1. A system with 5 
connected ILT 0 bioreactors was used, as shown in figure 14. 
For the Surface and Metabolic Scaling Model (see paragraph 3, chapter 4) 1 
HUVEC slide was placed in the bottom of the first chamber and 4 C3A 
slides were transferred to each of the other chambers of the system. The 
Cell Number Scaling Model (see paragraph 3, chapter 4) consisted in 1 
HUVEC slide placed in the bottom of the first chamber and 1 C3A slide in 
the second chamber, the other three chambers were left empty of cells 
(Figure 14 B). The circuits were closed and filled with 15 mL of ILT medium 
and run at 100 µL/min in the incubator for 72 h. 
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Fig. 14: The configuration of the two allometric models: the scheme of the Surface and 
Metabolic Scaling Model (SMSM) (A) and the Cell Number Scaling Model (CNSM) (B), and 
as they appear in reality (C). 
 
As control, the same type and number of coverslips were placed in a Petri 
dish with 15 mL of ILT medium. 
At the end of the experiment cells were analyzed for viability, morphology 
(HUVEC) and cytochrome activity (C3A) and medium was analyzed for 
  
65 
 
glucose, urea, D-lactate, glycerol, triglycerides (TG) and free fatty acids 
(FFA). 
 
3.4. NP dynamic testing with single tissue configuration 
HUVEC and C3A were tested for toxicity under dynamic conditions with 
different concentrations of Ag. The system used consisted in a 2 bioreactor-
connection, with HUVEC or C3A in the first or the second chamber as in 
figure 15. 
 
 
Fig. 15: The configuration of the two one tissue models: HUVEC experiment (A) and C3A 
experiment (B). 
 
15 mL of medium with Ag NP at different concentrations was used in order 
to match the volumes in the complete ILT system (paragraph 3.5). 
Cells were tested for viability, HUVEC were tested for vWF and C3A for α-
actin. Moreover soluble markers of inflammation and apoptosis were 
analyzed. 
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3.5. Evaluation of ILT complete system baseline 
A complete ILT system consists of one ILT 2 with CaCo-2 and two ILT 0 
respectively with HUVEC and C3A cells (as described in paragraph 3, 
chapter 3); each circuit has also a bubble trap before ILT 2 (Fig. 16) and 
sampling ports before the mixing bottles. Bubble traps are placed to avoid 
bubbles in the bioreactor that could affect both the flow and the TEER 
(Trans Epithelial Electrical Resistance) measurement while sampling ports 
are useful for sampling medium during the experiment in sterility without 
open the mixing chambers.  
  
Fig. 16: Scheme of complete three tissue ILT system 
 
Finally, the system was assembled as described in paragraph 1 and let run 
in the incubator for 24 h. A continuous measurement of TEER was taken 
using a modified EVOM 2 (WPI Inc, Sarasota, USA) that sends data to a 
dedicated software developed using LabVIEW (National Instrument, Austin, 
USA). 
Samplings were at definite time points (1 h, 3 h, 8 h, endpoint 24 h) and 
each experiment was analyzed with the assays listed in table 9. 
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SAMPLE ASSAY 
 
Cells on all Alamar  
CaCo-2 ZO-1 (tight junction) staining 
HUVEC vWF staining 
C3A Phalloidin staining 
Medium from all 
 
LDH  
Cytokine ELISA 
Apoptosis ELISA 
from C3A Albumin ELISA 
Tab. 9: List of assays performed within ILT system experiments 
 
Baseline values were determined both for positive and negative controls. 
The positive control was the three tissues ILT dynamic culture and the 
negative control was the three tissues ILT dynamic culture with Triton™ X-
100 added to the medium (in both mixing chambers). 
 
3.6. NPs testing in ILT system  
Polystyrene-FITC 55 nm NP (PS 50 nm) 1 mg/mL was firstly used to study 
the passage across the epithelial layer in the ILT complete system. Then, 
Ag was tested. The same protocol to assemble ILT system as for the 
baseline experiment was used (paragraph 3.5). 1 mg/mL of PS 50 nm or 
different concentrations of Ag NP were added only to the upper circuit 
(apical side with respect to CaCo-2 cells). 
The same assays listed for the baseline were performed for the PS and Ag 
NP experiment (Table 9). 
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4. ASSAYS 
 
4.1. Assays on cells 
Alamar viability Assay (Metabolic activity evaluation) 
Viability was tested at the end of the experiment using CellTiter™Cell 
Viability Assay (Promega, Madison, USA). Experimental medium was 
replaced with fresh medium and the reagent was added to the well in a 
volume correspondent to the tenth of the medium volume (e.g. for a 24-well 
plate 400 µL of medium were used and 40 µL of reagent were added), then 
the plate was placed in the incubator. Measurements of fluorescent 
emission with a fluorescent plate reader (Fluostar Optima, BMG Labtech, 
Aylesbury, UK) were after 30 minutes and after 2 hours and 30 minutes at 
590 nm. The slope of fluorescence increase was calculated (representing 
the specific metabolic activity) and expressed as percentage of control 
viability (untreated cells). 
 
Immunostaining and chemical staining (Function of cells) 
Immunostaining was performed to detect key role molecules in cells: von 
Willebrand Factor (vWF) for HUVEC and tight junction protein ZO-1 for 
CaCo-2. A chemical staining using fluorescent labeled phalloidin was also 
used to investigate the distribution of F-actin in C3A cells. 
After the experiment cells were fixed in iso-propanol 70 % over night. Then, 
washed cells were stained with the first antibody suspended in 2% BSA 
solution (Monoclonal Mouse Anti-Human Von Willebrand Factor, Dako, 
Glostrup, Denmark) for 1 h and after 3 washing steps the second antibody 
was added (AlexaFluor®, Invitrogen, Paisley, UK) to the cells. DAPI (4',6-
diamidino-2-phenylindole) staining was also performed to fluorescent label 
the nuclei.  
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Analysis of fluorescence was carried out using an optical microscope 
(AX70, Olympus Italia, Milan) with a 20X and 40X objectives or with a 
confocal microscope (Zeiss LSM 510 confocal microscope with the software 
LSM510 package). Captured images were analyzed and the stained 
proteins were semi-quantified using ImageJ software (National Institutes of 
Health, USA). 
 
Gluthation depletion assay (Oxidative stress evaluation) 
Experiments were run at different time points (2 h, 6 h, 24 h) as oxidation 
can occur very quickly and last for some hours. At the end of each 
experiment cells were scraped off and the acid extract was analyzed for 
GSH/GSSG content as described in Senft et al [104]. Briefly, 10 µL of acid 
extract from the trichloracetic acid (TCA) extraction were incubated 5 min 
with the Redox Quencing Buffer. Then, 29 µL of o-phtalaldehyde (OPT) 
solution were added and let react for 30 min. The fluorescence emission at 
420 nm of the reaction product was used to calculate the GSH value with 
respect to the standard curve values. A pre-step with dithionate was added 
to a second set of samples to reduce GSSG to GSH and then indirectly 
measure the GSSG content so to calculate the GSH/GSSG ratio.  
 
RNA extraction and quantification of vWF gene expression (HUVEC, 
function of cell) 
RNA from confluent wells of treated HUVEC was isolated using RNeasy® 
Mini Kit (Qiagen, Milan, Italy) and its content were verify measuring 
(Biophotometer, Eppendorf, Hamburg, Germany) the absorbance at 260 
nm. mRNA purity was evaluated calculating the ratio between absorbance 
value at 260 nm and the value at 280 nm  (A260/A280). 1 µg of RNA was 
reverse transcribed using QuantiTect® Reverse Transcription (Qiagen, 
Milan, Italy).  
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Real time PCR analysis was performed using DyNamo™ Flash SYBR® 
green qPCR kit (Finnzymes, Vantaa, Finland) for 39 cycles (95 °C for 10 s, 
60 °C for 30 s, 72°C for 30 s) using cycler specific pair of Primer (Forward 
primer VWF (exon 3) 5’-AGA AAC GCT CCT TCT CGA TTA TTG-3’; 
Reverse primer VWF (exon 4) 5'-TGT CAA AAA ATT CCC CAA GAT ACA-
3’). PCR products were identified by their melting curve. β-Actin was the 
housekeeping gene for HUVEC. 
 
Cytochrome P 450 activity (C3A, metabolism evaluation) 
At the end of the experiment C3A cells were tested for Cytochrome P 450 
(CYP 450) activity. Vivid® CYP450 3A4 Screening Kit (Invitrogen, Paisley, 
UK) was used to measure the cytochrome metabolism, the increase of 
fluorescence emission at 585 nm after substrate adding represents the 
fluorescent signal of produced metabolites. 
 
Transepithelial Electrical Resistance (CaCo-2, monolayer integrity) 
Transepithelial Electrical Resistance (TEER) was assessed with EVOM 2 
(World Precision Instruments, Sarasota, USA). When performed an ILT 2 
experiment TEER values were detected every 15 min and registered with a 
dedicated software developed using LabVIEW (National Instrument, Austin, 
USA).  
 
Morphology 
Cells morphology before and after experiments, was observed using an 
optical microscope (Olympus, AX70, Olympus Italia, Milan) with a 10X and 
20X objective. 
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4.2. Assays on medium 
Medium from every experiment was stored in order to measure soluble 
molecules concentration. From static culture and dynamic cells culture only 
endpoint media were stored. Sampling and endpoint media were, instead, 
analyzed in ILT complete system experiments. 
Each assay was carried out in accordance with the manufacturer’s 
instructions and at least a duplicate was measured for each sample. 
Media from NP testing on HUVEC static culture (paragraph 3.1) were 
analyzed for cytotoxicity Detection Kit (LDH, Roche, Germany), Fas-Ligand, 
ICAM-1, IL-8, and TNF-alpha with BD™ FLEX kit bead based ELISA (BD 
Biosciences, Franklin Lakes, USA). NP interference was evaluated in each 
assay. 
Media from allometric models experiments (paragraph 3.3) were analyzed 
for glucose, urea, D-lactate, glycerol, triglycerides (TG) and free fatty acid 
(FFA) concentrations using colorimetric and fluorimetric commercial kits 
(Glucose Test Kit, Megazyme International Ltd, Ireland; Urea Kit, Sigma-
Aldrich, St.Louis, USA; D-Lactate, Free Glycerol Assay kit, Triglyceride 
quantification kit, Free Fatty Acid Quantification Kit all from Biovision Inc., 
Milpitas, USA). Human albumin concentration was determined by an ELISA 
immunochemical assay (Bethyl Laboratories, Montgomery, USA).  
Media from one (paragraph 3.4) and three tissues (paragraphs 3.5 and 3.6) 
ILT experiments were analyzed for the same assays as for the NP testing 
on HUVEC static culture, moreover human albumin ELISA quantification 
was performed (not for HUVEC dynamic ILT experiment). 
  
5. STATISTICAL ANALYSIS 
Results were calculated from at least three different experiments and 
expressed as means ± standard deviation of the mean. Data were analyzed 
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by Student's t-test. Statistical significance was set at p<0.05 (indicated with 
*) and high significance was set at p<0.01 (marked with **). LC50 was 
calculated using Sigma Plot 11.0 (Systat Software, Inc., Erkrath, Germany). 
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Section III 
Results and Discussion 
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Chapter 6 
Results 
 
1. ESTABLISHMENT OF NPs TESTING ON HUVEC STATIC 
CULTURE  
 
NP toxicity on HUVEC cells was tested in order to determine the LC50 and 
investigate sub lethal effects such as loss of function or inflammation 
analyzing 3 relevant doses for each NP. 
 
1.1. Cell viability 
Dose dependent toxicity was assessed both for metabolic activity (Alamar 
Assay) and membrane integrity (LDH Assay). The Alamar assay evaluates 
the mitochondrial capacity to reduce the reagent to a fluorescent product, 
while the LDH assay measures the total amount of lactate dehydrogenase 
(LDH), a cytoplasmic enzyme in the medium, released from cells when the 
cellular membrane is damaged. 
In both assays high toxicity was shown for Ag and TiO2 NP treated HUVEC 
with an LC50 of 24.6 µg/cm2 (Alamar Assay) and 1 µg/cm2 (LDH Assay) for 
Ag NP and 28 µg/cm2 (Alamar Assay) and 53 µg/cm2 (LDH Assay) with TiO2 
(Figure 17). 
High Ag interference was found with the LDH assay using the same amount 
of cell lysate with different concentrations of particles. A reduction in 
absorbance was measured for treatment with Ag NM 300 NP at 
concentrations higher than 20 µg/cm2. This interference is characteristic of 
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enzymatic assays and is thought to be due to the adsorption of the enzyme 
onto the particle surface, reducing the enzyme activity [105]. However, when 
corrected for the particle interference a very strong cytotoxic effect was 
revealed as shown in figure 17 B. 
 
  
   
Fig. 17: Viability dose response curve for Ag (A and B) and TiO2 (C and D) exposed HUVEC. 
Viability was assessed both at the level of metabolic activity level (A and C) and membrane 
integrity (B and D). Data are expressed as percentage of untreated HUVEC viability; mean ± 
SD, * p<0.05 and ** p<0.01, n=3  
 
The Ag dispersant was also checked, and no toxicity at relevant 
concentrations was observed (Figure 18). 
 
 
A
   
D C
   
B
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Fig. 18: Viability dose response curve for Ag Dispersant treated HUVEC. Viability was 
assessed both at the level of metabolic activity (A) and membrane integrity (B). Data are 
expressed as percentage of untreated HUVEC viability; mean ± SD, n=3 
 
No significant toxicity with Polystyrene 50 nm (PS 50 nm) and Polystyrene 
200 nm (PS 200 nm) was observed (Figure 19), while low toxicity was 
shown for both Au particle sizes at higher concentrations (Figure 20). 
The outliers which showed significant higher viability with respect to control 
values are thought to be due to particle interference as already discussed. 
 
   
  
Fig. 19: Viability dose response curve for Polystyrene-FITC 50 nm (A and B) and 200 nm (C 
and D) treated HUVEC. Viability was assessed both at the level of metabolic activity (A and 
A
   
B
   
A
   
DC
B
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C) and membrane integrity (B and D). Data are expressed as percentage of untreated 
HUVEC viability; mean ± SD, * p<0.05 and ** p<0.01, n=3. 
 
  
  
Fig. 20: Viability dose response curve for Au 15 nm (A and B) and 80 nm (C and D) treated 
HUVEC. Viability was assessed both at the level of metabolic activity (A and C) and 
membrane integrity (B and D). Data are expressed as percentage of untreated HUVEC 
viability; mean ± SD, * p<0.05 and ** p<0.01, n=3. 
 
1.2. Oxidative stress 
When cells are subjected to an oxidative stimulus reduced glutathione GSH 
(γ-glutamylcysteinylglycine) is converted to GSSG, its oxidized form. The 
accumulation of GSSG determines a decrease in the GSH/GSSG ratio 
which is a signal of increased levels of oxidative stress. Ideally, the 
evaluation of GSH/GSSG ratio should be performed at early time points as 
oxidative stress can occur in the early steps of the cell response to the 
stimulus.  
The glutathione depletion assay was performed on HUVEC cultured in 12 
well-plates and treated with NPs at different time points (2 h, 6 h, 24 h). 
Unfortunately no detectable GSH was found as all the samples were out of 
B
   
A
C D
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the range of detection. Increasing the amount of cells it is possible to 
measure some GSH as shown in figure 5. However, a suitable value is only 
reached when a large number of cells are used, so this assay was found to 
be not feasible for the evaluation of oxidative stress on HUVEC cells in the 
ILT system. 
 
Fig. 21: GSH concentration with respect to the cell concentration (untreated cells). More than 
3 x 106 cells/mL are needed to reach a suitable value for GSH evaluation, n=1. 
 
1.3. Inflammation 
Inflammation was assessed measuring HUVEC cytokine release after NP 
treatment. Three concentrations for each NP type were tested, from 160 to 
5 µg/cm2 for low-toxicity NPs and from 20 (or 40) to 1 µg/cm2 for high-toxicity 
ones.  
 
1.3.1. Interleukin 8 (IL-8) 
IL-8 is a pro-inflammatory protein stored in the Weibel-Palade bodies and 
released in case of stress and inflammation. 
PS NPs of both sizes had IL8 expression comparable to controls with a 
slight decrease at highest concentration. Ag, TiO2 and Au of both size 
showed instead, a significant increase with respect to the controls 
(untreated). The increase was also found to be concentration dependent in 
all these particles. 
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Fig. 22: IL-8 release at different concentrations of NPs treated HUVEC. Data are expressed 
as concentration (pg/mL) in the medium; control sample is untreated HUVEC; mean ± SD, * 
p<0.05 and ** p<0.01 with respect to control, n=3. 
 
1.3.2. Intercellular Adhesion Molecule-1 or CD54 (ICAM-1) 
ICAM-1 is a transmembrane protein associated with intercellular adhesion. 
ICAM-1 signaling seems to produce a recruitment of inflammatory immune 
cells and as a consequence initiation of the inflammatory cascade.   
ICAM was only detected at a high concentration of polystyrene 50 nm. TiO2 
and Au showed highly significant (p<0.01) increase of ICAM with a peak at 
20 µg/cm2 of Au 80 nm. This concentration was able to stimulate ICAM 
release 28 fold more that in the controls. 
No ICAM release was observed from any Ag treated cells. 
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Fig. 23: ICAM-1 release at different concentrations of NPs treated HUVEC (ELISA Array). 
Data are expressed as concentration (pg/mL) in the medium; control sample is untreated 
HUVEC; mean ± SD, * p<0.05 and ** p<0.01 with respect to control, n=3. 
 
1.3.3. Tumor Necrosis Factor-α (TNF-α) 
TNF-α is a cytokine involved in systemic inflammation and is involved in the 
acute phase reaction. No detectable TNF-α was found in any of the 
samples. It is likely that the TNF-α concentration in the samples was too low 
to be detected.   
 
1.4. Apoptosis 
1.4.1. Fas-Ligand 
Fas ligand (CD95L) is a transmembrane protein. When the receptor binds it 
activates the caspase cascade with a consequent induction of apoptosis. 
Only in a few analyzed samples was Fas-L detectable. Ag treated HUVEC 
showed concentration dependent high apoptosis marker levels; surprisingly 
polystyrene beads 50 nm had the highest increase at a concentration of 160 
µg/cm2. This concentration did not show toxic effects in Alamar and LDH 
Assays.  
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Fig. 24: Fas-L release at different concentrations of NPs treated HUVEC (ELISA Array). Data 
are expressed as concentration (pg/mL) in the medium; control sample is untreated HUVEC; 
mean ± SD, * p<0.05 and ** p<0.01 with respect to control, n=3. 
 
1.5. Function of cells: von Willebrand Factor expression 
vWF is a glycoprotein present in blood plasma and produced constitutively 
in the Weibel-Palade bodies of endothelium. Its primary function is to bind 
other proteins and has an important role in the platelet adhesion pathway 
and coagulation cascade.  
High levels of vWF expression could mean an inflammation status. 
vWF expression was analyzed both at mRNA and protein expression levels 
for significantly toxic NPs (Ag and TiO2) and non-toxic ones (PS-FITC 50 nm 
and 200 nm)  
 
1.5.1. vWF mRNA quantification 
mRNA from NP treated HUVEC was extracted and real time PCR was 
performed in order to quantify the vWF mRNA expression . 
Au NPs of both sizes were found to increase vWF production indicating 
compromised HUVEC function. Polystyrene 50 nm (not the highest 
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concentration) and Ag NP at lower concentrations, instead, lead to high 
levels of vWF expression indicative of a relevant inflammatory status. 
 
 
Fig. 25: vWF mRNA expression at different concentrations of NPs treated HUVEC. Data are 
expressed as samples/control (untreated HUVEC) ratio; mean ± SD, * p<0.05 and ** p<0.01 
with respect to control, n=3. 
 
1.5.2. vWF protein expression 
vWF protein levels were also assessed for some NP (PS of both sizes, Ag, 
TiO2). NP treated HUVEC were fixed, stained for vWF and analyzed with a 
microscope. The immunocytochemical images of vWF staining were 
quantified using image processing. 
All images were taken at the same luminous intensity to ensure a constant 
background. The data were obtained from three wells per concentration and 
averaged using at least 3 regions of interest (ROIs) per well.  
PS-FITC NP of both sizes had a strong interference with the visualization of 
secondary antibody as the FITC absorption spectra (green) overlapped with 
the fluorescent spectra (red) of the antibody used to stain HUVEC. Image 
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processing was thus performed in order to discern the vWF signal from that 
of FITC as shown in figure 26. 
 
 
Fig. 26: Processed images showing co-localization of vWF and FITC (in green) and ROIs 
corresponding only to vWF (in orange) after 5 µg/cm2 50nm Polystyrene-FITC (A) and 5 
µg/cm2 200 nm Polystyrene-FITC (B), X20 objective. 
 
Results from image processing showed a constant and concentration 
independent expression of vWF in PS treated cells with respect to untreated 
samples. 
vWF expression from Ag treated HUVEC showed a peak of more than 
250% fluorescence at 3 µg/cm2 with respect to controls, while at higher 
concentrations the fluorescence dropped, either because there were fewer 
stained cells due to detachment of dead ones or because the vWF 
expression machinery was compromised (Fig. 27).   
A B 
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Fig. 27: Dose response curve of HUVEC treated with Ag NP at different concentrations. vWF 
expression is represented as the % of control red pixels after processing fluorescent 
micrographs; mean ± SD, n=3. A fluorescent micrograph (20X objective) for each 
concentration and control is also shown. 
 
The same even if lower increased expression trend was found with TiO2 
treated HUVEC. 
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Fig. 28: Dose response curve of HUVEC treated with TiO2 NP at different concentrations. 
vWF expression is represented as the % of control red pixels after processing fluorescent 
micrographs, mean ± SD, n=3. A fluorescent micrograph for each concentration and control 
is also shown. 
 
2. IDENTIFICATION OF COMMON DYNAMIC CULTURE 
CONDITIONS 
 
In order to perform a dynamic multiple cell type culture all the protocols 
need to be optimized. First of all a common medium suitable for all the 3 cell 
types need to be established. Then dynamic culture at different flow rates 
was tested in the new medium. 
 
2.1. Media testing 
Cells were tested in three different media (ECGM, EMEM, ILT medium) in 
standard static conditions analyzing viability every day for 3 days with 
Alamar Assay. Results were expressed with respect to the standard 
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(recommended medium for the cell type) medium value of the same day 
and with respect to the viability on the first day in order to evaluate the 
eventual difference in growth rate. 
2.1.1. HUVEC viability  
The standard medium for HUVEC is ECGM medium, so all the media were 
analyzed with respect to the ECGM daily value (Fig. 29 A) or with respect to 
ECGM viability value on day 1 (Fig. 29 B). 
Data showed that HUVEC were more metabolically activate in ILT medium 
with respect to control medium, while cells started dying after 3 days in 
EMEM. This trend was confirmed when cell growth was evaluated with 
respect to the control medium viability on day 1. HUVEC were proliferating 
in ILT medium even more than in ECGM medium, while in EMEM there was 
a decrease in proliferation. 
 
  
Fig. 29: Viability of HUVEC in different media; data plotted with respect to daily ECGM value 
(A) and with respect to ECGM value of day 1 in order to evaluate cell growth; mean ± SD, * 
p<0.05 and ** p<0.01, n=2. 
 
The viability data were confirmed by morphological analysis of HUVEC 
using a microscope, where cultivated in EMEM lose their typical 
cobblestone shape (as in fig. 30 A) and start detaching from the confluent 
layer (Fig. 30 B). 
 
A B 
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Fig. 30: HUVEC morphology after 24 h ECGM (A) and EMEM (B). 20 X objective. 
 
2.1.2. C3A viability 
The recommended medium for C3A is EMEM. Viability data for the different 
media were plotted with respect to controls either using the daily value (Fig. 
31 A) or with respect to EMEM viability value on day 1 (Fig. 31 B). Both 
viability and proliferation in ECGM or ILT medium were not significantly 
different from the control medium values. Cells reacted to each medium in a 
similar manner. 
 
  
Fig. 31: Viability of C3A in different media; data plotted with respect to the daily EMEM value 
(A) and with respect to the EMEM value of day 1 in order to evaluate the cell proliferation; 
mean ± SD, n=2. 
 
 
A 
A B 
A B 
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2.1.3. CaCo-2 viability 
The standard medium for CaCo-2 is DMEM but EMEM is also suitable 
medium for only 3 days of culture, so viability data were compared with 
respect to the EMEM value. No change in viability was found (Fig. 32 A) and 
a slight increase in growth was present for each medium (Fig. 32 B). 
 
  
Fig. 32: Viability of CaCo-2 in different media; data plotted with respect to the daily EMEM 
value (A) and with respect to EMEM value of the day 1 in order to evaluate cell growth; mean 
± SD, n=2.  
 
2.2. Dynamic condition set up 
Dynamic conditions suitable for all the cell types were tested. HUVEC and 
C3A were checked for viability (Alamar Assay) at different flow rates (CaCo-
2 was tested by another group) in ILT medium. Moreover functional marker 
analysis was performed. 
2.2.1. Viability 
Flow rates from 0 µL/min (cells in the ILT0 system with pump switched off) 
to 1000 µL/min were tested. Both cell types showed a good viability under 
flow rates below 500 µL/min. 
 
A B 
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Fig. 33: Viability of HUVEC (A) and C3A (B) at different flow rates; control samples were cells 
cultivated in the same conditions but maintained in a petri dish; 0 µL/min refers to cells in the 
dynamic system without the pump switched on. Mean ± SD, * p<0.05 with respect to control, 
n=2.  
 
2.2.2. Functional marker of HUVEC 
HUVEC from dynamic experiments were immunostained for vWF 
expression. 
A slight flow rate dependent increase was observed as described in 
Galbusera et al. [106]. 
 
  
A B 
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Fig. 34: Fluorescent micrograph of vWF stained HUVEC after 24 h in static conditions (A) 
and dynamic conditions with 100 µL/min (B) and 1000 µL/min flow rate (C). 20X objective.  
 
2.2.3. Functional markers of C3A 
C3A glucose uptake was analyzed to see whether cell metabolism depends 
on flow rates, moreover albumin and urea release in the medium were 
measured in order to check for the hepatocytes ability to produce 
metabolites. 
We did not observe significant differences in glucose and urea 
concentrations for the different flow rates. However there was a significant 
(p<0.01) increase in albumin release at 200 µL/min with respect to the 0 
µL/min control (Fig. 35 B). 
 
C 
A 
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Fig. 35: Markers of C3A function: glucose uptake (A), albumin release (B) and urea release 
(C) at different flow rates; static samples were cells cultivated in a petri dish; 0 µL/min were 
cells in the dynamic system without the pump switched on. Mean ± SD, ** p<0.01, n=2.  
 
3. ALLOMETRIC SCALING 
 
Two scaling models were studied experimentally. The “Surface and 
Metabolic Scaling Model” (SMSM) evaluates the surface area of liver and 
vascular endothelium considering physiological ratio while the “Cell Number 
Scaling Model” (CNSM) determines the cell number ratio scaling the total 
amount of hepatocytes and endothelial cells in the gastrointestinal tract. 
Media and cells from experiments were analyzed for cell metabolism and 
markers of hepatic function. 
 
3.1. Viability 
HUVEC and C3A cells were checked for viability with Alamar Assay. Both 
cells in the two experimental models showed good viability, to within 80% of 
static controls. 
 
3.2. Carbohydrate metabolism 
Carbohydrates are the primary source of energy and metabolic 
intermediates. Glucose is the main carbohydrate used by the cell in both 
aerobic and anaerobic respiration. Hepatocytes are able to store or release 
glucose through glycogen synthesis or glycolysis pathways.  
B C 
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D-Lactate levels seem to be function of both glycolysis and 
gluconeogenesis in hepatocytes [107]. D-Lactate participates in the 
glyoxalase pathway which is thought to help release the stress of elevated 
glucose intake, enhancing glycolysis and producing more lactate. 
Abnormally high concentrations of lactate have been related to disease 
states such as diabetes and lactate acidosis [108]. 
 
3.2.1. Glucose 
Glucose dosing in the media showed a higher uptake in the SMSM 
configuration. Anyway in both static and dynamic conditions the higher 
consumption of glucose can be attributed to the higher amount of cells with 
respect to the CNSM model (4 fold more). Significant (p<0.01) differences 
were observed between the two models in static conditions (Fig. 36). 
 
 
Fig. 36: Glucose uptake from cells in the two allometric model configurations. Static samples 
were the same type and number of cells cultivated in a petri dish. Mean ± SD, * p<0.05 and 
** p<0.01, n=3. 
 
3.2.2. D-Lactate 
A significant (p<0.05) decrease of lactate release in dynamic conditions was 
observed. No difference was found between the two models even when 
relating D-Lactate release with glucose uptake (Fig. 36), similar 
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concentrations of lactate were found in both configurations despite the lower 
uptake of glucose in the CNSM (Fig. 37). 
 
 
Fig. 37: D-Lactate release from cells in the two allometric model configurations. Static 
samples were the same type and number of cells cultivated in a petri dish. Mean ± SD, * 
p<0.05 and ** p<0.01, n=3.  
 
3.3. Fat metabolism 
The liver has a major role in the regulation both of glucose metabolism and 
fat metabolism. It can either oxidize and synthetize fatty acids and 
triglycerides sending them to energy production or to storage.  
Free fatty acids (FFA) and glycerol provided by ingestion or by drawing on 
triglycerides are used as substrates for ATP production. 
 
3.3.1. Triglyceride 
Triglyceride dosing showed that cells in the CNSM configuration took up 
about twice as much triglyceride content as the SMSM even though the total 
amount of cells present in the system was four time less. No significant 
change was observed between the static and dynamic set up in both 
models. 
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Fig. 38: Triglyceride uptake from cells in the two allometric model configurations. Static 
samples were the same type and number of cells cultivated in a petri dish. Mean ± SD, n=3.  
 
3.3.2. Free Fatty Acid 
Free Fatty Acid (FFA) data showed a variable trend between the two 
configurations. All data comparisons were highly significant (p< 0.01). 
In the SMSM configuration, high FFA uptake was observed for the static set 
up with a relevant lower uptake in the dynamic set up. In the CNSM the 
slight uptake in static conditions was contrasted by a highly significant 
release in the dynamic configuration (Fig. 39). This inversion of the trend is 
likely caused by HUVEC, which have a low level of FFA release in static 
conditions, while really high levels of free FFA are observed in dynamic 
conditions. HUVEC FFA motion was more prevalent than that of C3A which 
takes up FFA uptake in both static and dynamic conditions [98]. 
 
 
 
  
95 
 
 
Fig. 39: Free fatty acid uptake from cells in the two allometric model configurations. Static 
samples were the same type and number of cells cultivated in a petri dish. Mean ± SD, * 
p<0.05 and ** p<0.01, n=3.  
 
3.3.3. Glycerol 
The same level of glycerol was taken up by cells both static and dynamic 
states in the two configurations. A lower uptake was shown in the CNSM 
with respect to SMSM (Fig. 40). 
 
 
Fig. 40: Glycerol uptake from cells in the two allometric model configurations. Static samples 
were the same type and number of cells cultivated in a petri dish. Mean ± SD, * p<0.05 and 
** p<0.01, n=3.  
 
3.4. Function 
The liver is the key orchestrator of metabolism, many enzymatic reactions 
occur in this organ Healthy hepatocytes are able to perform carbohydrate, 
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lipid and xenobiotic metabolism, the synthesis of many molecules including 
albumin, and convert ammonia into urea. 
 
3.4.1. Cytochrome P450 subfamily 3A4 
The cytochrome P450 subfamily 3A4 (CYP3A4) is the main enzyme for drug 
metabolism and synthesis of cholesterol, steroids, and other lipid. 
Even if cell lines are thought to be less metabolically active and express low 
cytochrome enzyme levels [109], data showed a constant activity of CYP3A4 
in both SMSM configurations while a lower but not significant level was 
observed in the CNSM dynamic model with respect to static set up (Fig. 41). 
  
 
Fig. 41: CYP450 activity in the two allometric model configurations. Static samples were the 
same type and number of cells cultivated in a petri dish. Data expressed as metabolized 
product concentration, mean ± SD, n=3.  
 
3.4.2. Albumin 
Significant increase in albumin release was detected in the CNSM 
configuration where cells release twice more albumin than in SMSM. The 
content of albumin in each configuration was similar in static and dynamic 
conditions.  
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Fig. 42: Albumin release from cells in the two allometric model configurations. Static samples 
were the same type and number of cells cultivated in a petri dish. Data reported as 
concentration per coverslip; mean ± SD, * p<0.05 and ** p<0.01, n=3.  
 
3.4.3. Urea 
Urea release had the same trend as albumin. Significantly higher amounts 
of urea were released from cells in CNSM configuration (p<0.01) and even 
more in the dynamic set up (p<0.05). 
 
 
Fig. 43: Urea release from cells in the two allometric model configurations. Static samples 
were the same type and number of cells cultivated in a petri dish. Data plotted as 
concentration per coverslip; mean ± SD, * p<0.05 and ** p<0.01, n=3.  
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4. NP DYNAMIC TESTING WITH SINGLE TISSUE 
CONFIGURATION 
 
Different concentrations of Ag were studied with HUVEC and C3A, 
respectively, in dynamic conditions. 
The same assays as for the static NP testing, described in paragraph 1, 
were performed. 
 
4.1. HUVEC 
4.1.1. Cell viability 
Once more, cells were analyzed for viability with Alamar and LDH assays. 
Unfortunately the interference of Ag NP with LDH assay the (already 
observed in paragraph 1.1) made the data difficult to analyze since the 
amount of Ag NP in the samples from dynamic experiments is unknown 
(adsorption of NP on the bioreactor system walls and cell uptake can 
influence the NP concentration in the media) so it was not possible to 
subtract the zero background medium/Ag NP from the experimental 
samples. 
According to the Alamar data Ag was highly toxic to HUVEC cells under 
dynamic conditions from a concentration of 25 µg/mL, showing an LC50 of 
12.13 µg/mL.  
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Fig. 44: Viability dose response curve for Ag treated HUVEC under dynamic conditions. 
Viability was assessed in terms of metabolic activity. Data are expressed as percentage of 
untreated-static condition HUVEC viability; mean ± SD, * p<0.05 and ** p<0.01 with respect 
to static control, n= at least 3. 
 
4.1.2. Inflammation 
IL8, ICAM-1 and TNFα release were analyzed as markers of inflammation. 
A significant increase in IL8 release was found in Ag NP treated HUVEC 
under dynamic conditions at a concentration of 10 µg/mL. Higher 
concentrations showed almost no release, perhaps due to cell death. No 
ICAM-1 and TNFα was detected. 
 
Fig. 45: IL-8 release at different concentrations of Ag NP treated HUVEC under dynamic 
conditions. Data are expressed as concentration (pg/mL) in the medium; control sample is 
untreated dynamic HUVEC; mean ± SD, * p<0.05 and ** p<0.01 with respect to control, n=3. 
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4.1.3. Apoptosis 
Fas Ligand was measured in media sample from dynamic experiments. The 
results had high standard deviations because the concentrations measured 
were close to detection limits. A slight increase with increasing Ag NP 
concentration can be observed till 10 µg/mL Ag; at higher Ag levels Fas-
ligand appears to decrease. 
 
 
Fig. 46: Fas-L release at different concentrations of Ag NP treated HUVEC under dynamic 
conditions. Data are expressed as concentration (pg/mL) in the medium; control sample is 
untreated dynamic HUVEC; mean ± SD, n=3. 
 
4.1.4. Cell function: von Willebrand Factor expression 
vWF expression was significantly (p<0.01) lower than control at the highest 
concentration of Ag NP, likely due to cell death as explained in paragraph 
1.5. 
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Fig. 47: vWF expression at different concentrations of Ag NP treated HUVEC under dynamic 
conditions. Data are expressed as arbitrary units; control sample is untreated dynamic 
HUVEC; mean ± SD, * p<0.05 and ** p<0.01 with respect to control, n=3. 
 
4.2. C3A 
4.2.1. Cell viability 
C3A cells from dynamic experiments were analyzed with Alamar and LDH 
Only the Alamar assay is shown as Ag strongly interferes with the LDH 
assay as explained for HUVEC in paragraph 4.1.1. 
NP treated C3A under dynamic conditions showed an LC50 of 12.37 µg/mL.  
 
 
Fig. 48: Viability dose response curve for Ag treated C3A under dynamic conditions. Viability 
was assessed in terms of metabolic activity. Data are expressed as percentage of untreated 
C3A viability under static conditions; mean ± SD, * p<0.05 and ** p<0.01 with respect to 
control, n= at least 3.  
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4.2.2. Inflammation 
Significant (p<0.05) IL8 increase at low Ag NP concentrations was found 
while ICAM-1 had an increasing trend proportional to Ag NP concentration, 
before decreasing again due to cell death. No TNFα release was detected.  
 
  
Fig. 49: IL-8 (A) and ICAM (B) release at different concentrations of Ag NP treated C3A 
under dynamic conditions. Data are expressed as concentration (pg/mL) in the medium; 
control sample is untreated C3A (dynamic); mean ± SD, * p<0.05 and ** p<0.01 with respect 
to control, n=3. 
 
4.2.3. Apoptosis 
Significant amounts of Fas-Ligand were released by C3A cells when 
exposed to low concentrations of Ag NP in dynamic conditions (p<0.01 with 
respect to control). Fas-Ligand was undetectable at higher more Ag toxic 
concentrations.  
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Fig. 50: Fas-L release from C3A under dynamic conditions as a function of Ag NP 
concentration. Data are expressed as concentration (pg/mL) in the medium; control sample is 
untreated C3A (dynamic); mean ± SD,* p<0.05 and ** p<0.01 with respect to control, n=3. 
 
4.2.4. Cell function: albumin release and phalloidin expression 
Albumin concentrations dropped significantly (p<0.01) when Ag NP 
concentrations greater than 10 µg/mL were administered, indicating 
damage in protein synthetic function cell state at these concentrations.  
 
Fig. 51: Albumin release at different concentrations of Ag NP treated C3A under dynamic 
conditions. Data are expressed as concentration (ng/mL) in the medium; control sample is 
untreated dynamic C3A; mean ± SD, * p<0.05 and ** p<0.01 with respect to control, n=3. 
 
Phalloidin expression also dropped above the same Ag concentrations as 
did albumin. 
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Fig. 52: Phalloidin expression at different concentrations of Ag NP treated C3A under 
dynamic conditions. Data are expressed as arbitrary units; control sample is untreated 
dynamic C3A; mean ± SD, * p<0.05 and ** p<0.01 with respect to control, n=3. 
 
5. EVALUATION OF ILT SYSTEM BASELINE  
 
ILT complete system was firstly checked for baseline. Negative, untreated 
connected dynamic culture, and Positive, TRITON X (surfactant) spiked 
medium connected dynamic culture, controls were used.  
The same assays as for the static NP testing, described in paragraph 1, 
were performed. 
 
5.1. Cell viability 
Viability was tested directly on cells using Alamar Assay and media from the 
same experiments was used to assay LDH released from cells. When the 
Alamar Assay was performed a viability value for each cell type was 
obtained; while evaluating LDH in the media two values were measured, 
one from the upper circuit medium representing LDH released from CaCo-2, 
and the other from the lower circuit medium  which is the LDH released from 
HUVEC and C3A. 
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CaCo-2, HUVEC and C3A cells showed a good viability in the connected 
system set up. The positive control (dead cells), as expected had a huge 
decrease in viability according to the Alamar Assay. 
 
 
Fig. 53: Viability of cells (CaCo-2, HUVEC and C3A) in the ILT system connected culture. 
Negative control is the untreated cells in the ILT system and Positive Control is Triton X 
treated cells. Data are expressed as percentage of static cell culture viability, mean ± SD, * 
p<0.05 and ** p<0.01, n=4. 
 
Media sampled from upper and lower circuits showed an increased in LDH 
release in the positive control (TRITON X spiked medium) while values 
close to the detection limit in the negative control resulted in high standard 
deviations. Plotting the LDH trend with respect to time (Fig. 55) showed that 
healthy cells (values lower than 1) were clearly different from dead cells 
values (higher than 1).  
 
  
Fig. 54: LDH release from cells in the ILT system connected culture from media sampled in 
the upper (A) and the lower circuit (B). Negative control is the untreated cells in the ILT 
A B 
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system and Positive Control is Triton X treated cells in the ILT system. Data are expressed 
as arbitrary units, mean ± SD,* p<0.05 and ** p<0.01, n=3. 
 
 
Fig. 55: LDH release from cells in the ILT system connected culture from the upper and the 
lower circuit medium sampling. Negative control is the untreated cells in the ILT system and 
Positive Control is Triton X treated cells. Data are expressed as arbitrary units, mean ± SD, 
n=3. 
 
5.2. Inflammation 
No IL8 release either from negative or positive controls was found (TRITON 
X did not stimulate IL8 release). High release of ICAM, instead, was found 
in the positive (TRITON X) control media. 
 
  
Fig. 56: ICAM release from cells in the ILT system connected culture from the upper (A) and 
the lower circuit (B). Negative control is the untreated cells in the ILT system and Positive 
Control is Triton X added medium in the ILT system. Data are expressed as concentration 
(pg/mL), mean ± SD,* p<0.05 and ** p<0.01, n=3. 
 
A B 
  
107 
 
5.3. Apoptosis 
No detectable Fas-Ligand release was found in any of the analyzed 
samples. 
 
5.4. Function of CaCo-2: TEER 
Trans epithelial electrical resistance (TEER) was measured in order to 
monitor the integrity of the epithelial barrier. The expression of tight 
junctions within the epithelial cell layers, also give a measure of cell integrity 
and functionality.  
CaCo-2 maintained their membrane properties during the baseline control 
experiment showing a constant TEER value of about 1800 Ω. 
 
 
Fig. 57: CaCo-2 TEER trend in the ILT system connected culture in the negative control 
baseline experiment. Data are expressed as resistance (Ohm) during the experiment. 
 
Rapid loss of barrier function was observed in the positive control (data not 
shown). 
 
5.5. Function of HUVEC: von Willebrand Factor expression 
HUVEC cells were stained for vWF (as described for the static protocol) 
after each experiment. Digital images of cells were analyzed by quantifying 
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the total intensity of red pixels using ImageJ. The analysis showed a 
significantly (p<0.01) higher fluorescence in the negative control with 
respect to positive control.  
 
 
Fig. 58: vWF expression in the ILT system connected culture. Negative control is the 
untreated HUVEC culture in the ILT system and Positive Control is Triton X spiked medium in 
the ILT system. Data are expressed as arbitrary units, mean ± SD,* p<0.05 and ** p<0.01, 
n=3. 
 
5.6. Function of C3A: albumin release and phalloidin expression 
C3A hepatocytes release high amounts of albumin in the lower 
compartment in baseline conditions. On the other hand when the negative 
control experiment was performed, lower release was found in the positive 
control where the cells were exposed to Triton surfactant. No albumin was 
found in the upper circuit in the negative control experiment while some 
really low concentration can be detected in the positive control where the 
epithelial barrier was clearly damaged, allowing the passage of molecules 
from the lower to upper circuit. 
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Fig. 59: Albumin release from C3A in the ILT system connected culture from the upper (A) 
and the lower circuit (B). Negative control is the untreated cells in the ILT system and 
Positive Control is Triton X spiked medium in the ILT system. Data are expressed as 
concentration (ng/mL), mean ± SD, n=3. 
 
Microscopic analysis of hepatocytes stained for phalloidin showed a highly 
significant (p<0.01) difference between the two experimental protocols with 
almost no expression in the positive control.  
 
 
Fig. 60: Phalloidin expression in the ILT system connected culture. Negative control is the 
untreated cells in the ILT system and Positive Control is Triton X spiked medium in the ILT 
system. Data are expressed as arbitrary units, mean ± SD, * p<0.05 and ** p<0.01, n=3. 
 
6. NPs TESTING IN ILT SYSTEM  
 
In this section the NP testing within the ILT system was reported. 
Polystyrene-FITC 55 nm NP was used to characterize the system, and then 
preliminary results from Ag NP testing were shown. 
A B 
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6.1. Polystyrene-FITC 55 nm NP 
In order to evaluate the passage across the intact epithelial barrier, 
polystyrene-FITC 55 nm NP (PS NP) were used. A high upper circuit 
concentration (1mg/mL) was chosen in order to have a detectable lower 
circuit concentration. Moreover viability, inflammation, apoptosis and cell 
function were tested. 
 
6.1.1. Viability 
Cells showed a good viability with respect to controls, comparable to the 
static condition toxicity analysis. 
 
 
Fig. 61: Viability of cells (CaCo-2, HUVEC and C3A) in the ILT system connected culture. 
Negative control is the untreated cells in the ILT system and Positive Control is Triton X 
treated cells in the ILT system. Data are expressed as percentage of static cell culture 
viability mean ± SD, n=3. 
 
6.1.2. Inflammation 
A significant (p<0.01) IL8 release was found in the lower circuit, while 
almost no ICAM was released from both circuits. 
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Fig. 62: IL8 (A) and ICAM (B) release from cells in the ILT system connected culture from the 
upper and the lower circuit medium sampling. Negative control is the untreated cells in the 
ILT system and Positive Control is Triton X spiked medium in the ILT system. Data are 
expressed as concentration (pg/mL), mean ± SD, * p<0.05 and ** p<0.01 with respect to 
negative control, n=3. 
 
6.1.3. Apoptosis 
No Fas-L release was observed in the PS NP experiment. 
 
6.1.4. Function of CaCo-2: TEER 
A constant TEER value of 1934.24 ± 109.17 Ω was maintained during the 
PS NP experiment (data not shown). 
 
6.1.5. Function of HUVEC: vWF expression 
Expression of vWF from HUVEC in the lower circuit of PS-FITC 50 nm 
experiment was found to be slightly lower than the control sample. 
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Fig. 63: vWF expression from HUVEC in the ILT system connected culture. Negative control 
is the untreated cells in the ILT system. Data are expressed as arbitrary units, mean ± SD, * 
p<0.05 and ** p<0.01 with respect to control, n=3. 
 
6.1.6. Function of C3A: albumin release 
Albumin levels were comparable to negative controls in both circuits in the 
PS NP experiments. 
 
 
Fig. 64: Albumin release from C3A in the ILT system connected culture from the upper and 
the lower circuit. Negative control is the untreated cells in the ILT system and Positive 
Control is Triton X medium in the ILT system. Data are expressed as concentration (ng/mL), 
mean ± SD, n=3. 
 
6.1.7. PS-FITC 50 nm NP passage evaluation 
100 µL of medium sampled from lower circuit at 1 h, 3 h, 8 h, 24 h were 
measured. All samples were found to be under the limit of detection (0.01 
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mg/mL). However subsequent confocal analysis showed fluorescent PS 
NPs on HUVEC and C3A coverslips after 24 h of PS NP circulating in the 
upper circuit of the ILT complete system (Fig. 65 and 66). This indicates that 
the NPs did cross the epithelial barrier. 
 
 
Fig. 65: PS-FITC NP (green dots) on HUVEC cells after passage across the intestinal 
epithelium in the ILT complete system. Fluorescent micrograph (on the left) and its 
overlapping with white light image (on the right). Magnification 63 X plus zoom 20. 
 
 
Fig. 66: PS-FITC NP (green dots) on C3A cells after passage across the intestinal epithelium 
in the ILT complete system. Fluorescent micrograph (on the left) and its overlapping white 
light image (on the right). Magnification 63 X. 
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6.2. Ag NP preliminary results 
Two concentrations (50 µg/mL and 200 µg/mL) of Ag NP were tested in the 
ILT complete system and standard analyses were performed. Preliminary 
results are shown. 
 
6.2.1. Viability 
CaCo-2 viability decreased with increasing concentrations of Ag NP (50 to 
200 µg/mL), while cells in the lower circuit maintained a good viability. 
 
  
Fig. 67: Preliminary viability results (CaCo-2, HUVEC and C3A) from Ag NP experiments in 
the ILT connected culture system. Negative control is the untreated cells in the ILT system 
and Positive Control is Triton X treated cells in the ILT system. Data are expressed as 
percentage of static cell culture viability mean ± SD, n=3 for controls, n=1 for Ag NP. 
 
6.2.2. Inflammation 
High inflammation through the IL8 pathway but not ICAM was found in the 
lower circuit of samples from Ag NP experiments. Slightly higher ICAM 
concentrations with respect to controls were found in the upper medium. 
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Fig. 68: Preliminary IL8 (A) and ICAM (B) release results from Ag NP experiments in the ILT 
connected culture system from the upper and the lower circuit. Negative control is the 
untreated cells and Positive Control is Triton X treated cells in the ILT system. Data are 
expressed as concentration (pg/mL) ± SD, n=3 for controls, n=1 for Ag NP. 
 
6.2.3. Apoptosis 
No apoptosis marker was found in the analyzed samples. 
 
6.2.4. Function of CaCo-2: TEER 
A constant decrease in the TEER value was measured in CaCo-2 cells 
exposed to Ag 50 µg/mL during the experimental time. 
 
 
Fig. 69: CaCo-2 TEER trend in the connected culture ILT system in the Ag 50 µg/mL 
experiment. Data are expressed as resistance (Ohm) during the experimental time 
 
In the Ag 200 µg/mL experiment a quicker drop down in the TEER value 
was observed (data not shown). 
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6.2.5. Function of HUVEC: vWF expression 
No change in HUVEC vWF expression was observed in the Ag 50 µg/mL 
experiment (upper circuit only), while a slight decrease was detected when 
adding Ag 200 µg/mL to the upper circuit of the ILT system. 
 
Fig. 70: vWF expression from HUVEC in the connected culture ILT system. Negative control 
is the untreated cells in the ILT system. Data are expressed as arbitrary unit ± SD, n=3 for 
controls, n=1 for Ag NP. 
 
6.2.6. Function of C3A: albumin release 
A concentration dependent decrease in albumin release was found with 
respect to control sample. 
 
Fig. 71: Preliminary Albumin release results from Ag NP experiments in the ILT system 
connected culture from the upper and the lower circuit. Negative control is the untreated cells 
in the ILT system and Positive Control is Triton X treated cells in the ILT system. Data are 
expressed as concentration (ng/mL) ± SD, n=3 for controls, n=1 for Ag NP. 
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Chapter 7 
Discussion 
 
The aim of this thesis is the validation of a new in vitro method to assess 
NPs toxicity so as to gain new insights into the nano-world and its safety. 
Development of a new method means creating a new system and new 
optimized protocols to use it. Further, the more integrated is the system, the 
more simplifications are needed to deal with the process step by step (from 
static culture to dynamic culture to connected dynamic culture) and be able 
to understand data from the most complex method. 
Finally in order to validate a new method comparison with standard 
protocols is required, to see whether improvements come out from the new 
approach. 
 
1. ESTABLISHMENT OF NPs TESTING ON HUVEC STATIC 
CULTURE  
The standard in vitro method accepted by the scientific community is 
certainly the petri dish/multiwell cell culture. Besides providing comparative 
data, the standard cell culture experiments definitely represent a first, if 
somewhat simplistic, insight into NP toxicity on HUVECs. Knowing the effect 
of chosen the NPs on a simple culture also serves to better orient the ILT 
system approach. 
NPs toxicity and sub lethal effects on HUVEC were checked at different 
levels, with different assays. The reason for this choice was due to the NP 
interference with assays as already mentioned in paragraph 1.1, chapter 6. 
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When data from two different assays are concordant with each other the 
probability that we have reliable data is really high [110]. 
Both Alamar Assay and LDH Assay confirmed that Ag NP and TiO2 NP 
were highly toxic for HUVEC (Fig. 17, chapter 6); although was not possible 
to overlap the LC50 values, maybe due to difference in the sensitivity of the 
two methods. In any case the LC50 values were both very low. 
Polystyrene-FITC of both sizes (PS 50 nm and PS 200 nm) were not toxic 
while a slight toxicity can be ascribed to Au NPs (both sizes). Data from 
these NPs also confirmed that neither viability assay was subject to 
interference. As matter of fact these chosen assays have really different 
experimental protocols: the Alamar Assay has to be performed directly on 
cells and is based on their capability to metabolize a reagent (added to fresh 
medium without suspended tested NPs); the LDH assay is an enzymatic 
assay performed on medium samples to detect LDH release from damaged 
cells. Viability is the basic level to assess toxicity so it’s really important to 
have meaningful data from more than just one assay. 
Yet, NPs have many other effects besides cell death [111]. Often NPs 
induces oxidative stress or inflammation and can lead to apoptosis or 
necrosis [112-114]. Based on this principle other markers were assayed. 
Oxidative stress due to free radical formation in the presence of NPs is one 
of the most important sub-lethal reactions to occur in cells after NP 
treatment [115], [116]. Unfortunately, no detectable marker of oxidation was 
found using the GSH assay. This was attributed to the relatively low number 
of cells which did not produce a suitable GSH concentration for detection 
(Fig. 21). As the number of cells is even lower in ILT system than in the 
standard, leading anyway to undetectable comparable data the GSH assay 
was eliminated from the test list. 
Continuing with sub lethal analysis, inflammation was studied evaluating 
either IL8 and ICAM-1, and TNFα as markers. No detectable TNFα was 
measured in any of the samples. High IL8 levels were found in all samples 
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except for PS NPs, which showed a small decrease at the highest 
concentration (Fig. 22). Only PS 50 nm at highest concentration had a slight 
increase in released ICAM (Fig. 23), suggesting that relevant concentrations 
of these particles do not induce inflammation, and only high amounts of the 
smaller PS (50 nm) initiate pro-inflammatory signals. The most toxic NPs, 
Ag and TiO2, released a huge amounts of IL8, but only in TiO2 samples was 
ICAM release increased. This result was really interesting, hinting the point 
that inflammation can be triggered at different levels and involve different 
markers (ICAM-1 is known to be stimulated by IL1 and TNFα [117-119]) 
depending of the type of NPs. In fact, Au NPs showed both high release of 
IL8 and ICAM-1 (Fig. 22 and 23), higher ICAM for Au 80 nm with respect to 
Au 15 nm while higher levels of IL8 were observed for the smaller Au NPs. 
These NPs seem to activate both pathways, but in a size dependent 
manner.  
In summary, Ag trigged inflammation through an IL8 involved pathway and 
did not have any effect on ICAM. Both TiO2 and Au 15 nm triggered 
inflammation by IL8 and ICAM pathways, but principally the one involving 
IL8, while Au 80 nm evidently activates the ICAM signaling pathway to a 
greater extent than the IL8 one.  
Whatever the pathway is, the data showed as almost every NP induces 
inflammation, even at low concentrations. 
It is possible to theorize for Ag NP, for example, a first state of inflammation 
that can lead to some apoptosis (Fig. 24) and cell death. A different 
process, not ending in cell death, was found with PS 50 nm NP, which 
induced slight (Fig. 23) or no inflammation (Fig. 22) but had an interesting 
increase in Fas-L, the apoptosis marker. It seems that these NPs induce at 
most a slight inflammation by a non-IL8 pathway that then induces the 
initiation of apoptotic processes. 
Looking at the functional marker, von Willebrand Factor, a nice correlation in 
the trend of its two expression levels in Ag treated cells is shown. After an 
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increase in the vWF expression around a few µg/mL of Ag NP, the signal 
dropped down at both mRNA (Fig. 25) and protein level (Fig. 27). This 
decrease can be ascribed to cell death which resulted in fewer cells being 
stained or processed for mRNA extraction. However, no correlation in the 
TiO2 treated cells between mRNA and protein expression was observed for 
vWF. A similar to Ag trend was present in the vWF staining for the TiO2 
treated HUVEC (Fig. 28) even if a lower increase at 3 µg/mL of 
concentration was found; on the other hand mRNA expression decreased 
with TiO2 concentration. This inconsistency was maybe caused to the high 
interference of the particles with the extraction (purity of mRNA content for 
TiO2 treated cells was always low, in a concentration dependent manner). 
As matter of fact, considering the high level of inflammation through different 
pathways and the high interference with mRNA extraction, it is likely that 
even vWF expression was increased, in accordance with the vWF 
immunostaining data. 
mRNA expression data showed that Au 15 nm but not Au 80 nm was able to 
slightly compromise HUVEC functionality of vWF production (Fig. 25). 
No relevant vWF expression from PS NPs was observed, confirming that 
these NPs do not trigger inflammation. 
Those data all together (summarize in table 10) represent a first insight into 
NP toxicity on HUVEC cells.  
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Tab. 10: Summary of determined toxicity levels of tested nanoparticles on HUVEC cells; ND 
= not determined; green = not toxic over the determined concentration range; yellow = slight 
toxicity at high concentrations; orange= medium toxicity and red = high toxicity 
 
The data showed that some NPs like Ag and TiO2 were more toxic than 
others. Moreover, sub-lethal effects showed that other outcomes besides 
the impairment in viability can occur in NP treated cells. In fact, low toxicity 
PS 50 nm NP was shown not to induce any inflammation, but did induce the 
apoptotic pathway, which may underlie a low level in cell death. Were only 
data on inflammation to be recorded, it could lead to a wrong safety 
classification. 
In addition a high dependency on NP type (Ag, TiO2 and Au) and even sizes 
(Au 15 and Au 80 nm NPs) in the induced effects is evident.  
Finally, different pathways can be involved behind the high levels of 
inflammation observed in most cases, once more depending on the type 
and size of NPs. 
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2. IDENTIFICATION OF COMMON DYNAMIC CULTURE 
CONDITIONS 
The first step in an in vitro co-culture is to find the optimum conditions for 
the common culture. Different media from the simplest to the most enriched 
one were tested. HUVEC cells were found to be the most sensitive cells to 
different media (Fig. 29); this result was not surprising since these were the 
only primary cells to be used in the experiments (CaCo-2 and C3A are cell 
lines). C3A did not appear to be influenced by medium content variations 
(Fig. 31) while CaCo-2 proliferation was stimulated to by all the media but it 
had a constant trend in the ILT medium (Fig. 32). According to these data 
the ILT medium was chosen as the best one for co-culture.  
As the ILT approach involves not only connected culture but also flow 
conditions, it is necessary to find the optimum range of flow rates.  
It is known from Mazzei et al. [93] that the limit for the ILT0 bioreactor to have 
laminar flow and suitable oxygen concentration is 1 mL/min; several flow 
rates below this limit were tested both with HUVEC cells (more sensitive as 
primary cells but more resistant to shear stress) and C3A cells (more 
resistant as cell line but sensitive to shear stress). 
Good viability was found at flow rates lower than 500 µL/min, while C3A had 
a peak of viability at 80-100 µL/min, HUVEC did better at slight higher flows 
between 100-250 µL/min (Fig.33).  
Looking at the functionality markers, HUVEC showed constant or slightly 
increased expression of vWF from 100 to 1000 µL/min (Fig. 34), while C3A 
had a slightly higher uptake of glucose under flow with respect to static 
conditions (Fig. 35 A), a significant increase from 0 to 200 µL/min of albumin 
release (more healthy cells accordingly to the viability data) and a constant 
urea release (Fig. 35 B and C).  
An important point is that all the samples were compared with respect to a 
control which was not only same cells and culturing day with respect to the 
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dynamic ones but also same type and volume of medium in order to avoid 
problems like concentration dependent release. 
It is clear from the viability and cell function results that the best flow rate for 
HUVEC and C3A cells, that is for the lower ILT system circuit, was 100 
µL/min. Results from flow rate testing of CaCo-2 (testing was performed by 
another research group) showed a good viability at any flow rate below 1 
mL/min, so 200 µL/min was chosen as the flow rate for the upper circuit 
(intestinal barrier) in order to increase the passage of NPs (thanks to a 
higher upper flow rate with respect to the lower) and the number of times 
the medium circulates during a single experiment, so mimicking a bigger 
surface area for intestinal epithelia. 
 
3. ALLOMETRIC SCALING 
In order to recreate the most physiological in vitro system for the intestinal 
tract, two different allometric scaling models were tested.  
The reader is reminded that SMSM is the acronym for “Surface and 
Metabolic Scaling Model” containing 25 000 HUVEC cells and 1 000 000 
C3A cells; while CNSM is the “Cell Number Scaling Model” with 25 000 
HUVEC cells and 250 000 C3A cells. 
Focusing on the metabolic compartment we studied relationship between 
hepatocytes and endothelial cells, their cross-talk and tried to identify which 
of the two models better represents physiological state. 
With this aim we analyzed metabolic and functional markers.  As viability 
data were good in both models, the study was focused on hepatocytes 
which are multi-functional cells able to perform both carbohydrate and fat 
metabolism and storage. The model closer to the in vivo situation will be the 
one to be use in the ILT system. 
Starting from the simplest and main metabolic analysis, glucose 
concentration was significantly lower in the SMSM configuration than the 
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CNSM (Fig. 36), meaning a higher uptake of sugar from the medium. This 
data anyway could be due to the higher number of cells in the SMSM (about 
4 fold more) with respect to CNSM. In fact considering the concentration per 
cell, in the CNSM cells consumed more glucose in the dynamic set up with 
respect to the SMSM. In face of a higher uptake of glucose, higher D-lactate 
amounts per cell were released in CNSM, reaching total D-lactate values 
similar to the SMSM configuration (Fig. 37). It is known that in vivo high 
glucose uptake corresponds to increased production of D-lactate through 
the glyoxalase pathway; a similar mechanism may have occurred in the 
CNSM configuration. In fact in this model we observed more glucose intake 
per cell and also a higher D-lactate release that reached the level of the in 
SMSM (due to higher amount of cells). This could indicate that CNSM was 
more able to equilibrate the stress of high cytoplasmic glucose 
concentrations. 
The second most important mechanism for energy production in humans is 
fat metabolism.  
Relevantly higher triglyceride uptake was shown in the CNSM where the 
triglyceride concentration per cell in the dynamic set up was 8 fold less with 
respect to the concentration per cell in the SMSM (Fig. 38). This result 
means that cells in the CNSM were undergoing higher triglyceride turnover 
than in the SMSM, so indicating that in the CNSM cells were producing 
energy by fat metabolism at a higher level than in the SMSM. 
The FFA uptake results are interesting and significant (p<0.01) (Fig 39).  
It is known from Vinci et al.[98] that FFA uptake in hepatocytes does not differ 
between the static and dynamic set up; in contrast HUVEC cells are highly 
sensitive to flow and the FFA turnover is inverted: the cells uptake FFA in 
static conditions and release it in high amounts under flow conditions.  
Keeping this in mind, the data in figure 39, chapter 6, can be interpreted as 
a sort of additive effect from static to dynamic, performed by HUVEC and 
hepatocytes. In static condition HUVECs slightly helped the FFA uptake of 
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C3A, which had the predominant role being considerably more cells with 
respect to HUVEC. The amount of cells also explains why the uptake in 
SMSM model was higher (6 fold more) than that in CNSM with lower cells 
content. The most interesting behavior in FFA motion was surely 
represented by the dynamic condition. In this configuration HUVEC 
competed with hepatocytes in the direction of FFA movement: lower uptake 
was shown in SMSM as the few amount of HUVEC (40 fold less cells) 
releasing FFA cannot overpass the high uptake of hepatocytes.  
A complete overturn in the FFA trend was carrying out by HUVEC in the 
dynamic CNSM configuration, where high FFA release from HUVEC hided 
the C3A uptake, resulting in a final release. This high secretion of FFA can 
be due to the higher metabolism of triglyceride as confirmation that this 
molecule was not only up taken but also metabolized. 
Glycerol data showed no difference between static and dynamic (Fig. 40); in 
SMSM uptake was slightly more than in CNSM, anyway there is reason to 
believe that a higher uptake of glycerol in CNSM configuration was hidden 
by some glycerol released from the high triglyceride metabolism. In CNSM, 
triglyceride and FFA analysis demonstrated as triglycerides were highly took 
up and also consumed. From each metabolized triglyceride molecule 3 FFA 
and one glycerol is released, so there should be a high release of glycerol 
together with the uptake measured in the samples. This consideration led to 
a theoretical higher intake of glycerol in CNSM with respect to SMSM, 
meaning again a higher metabolism. 
In conclusion metabolism analysis showed a closer to in vivo physiology for 
CNSM model with an in vivo D-lactate trend, high fat metabolism with higher 
amount of products. 
At this point, functional marker analysis is really important to see whether 
these results correspond to a higher functional state of cells in CNSM.  
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According to Cyt P450 evaluation lower metabolic activity was attributed to 
dynamic CNSM configuration. Anyway has to be underlining as cytochrome 
P450 3A4 is only one isoform of the hundreds housed in hepatocytes. 
Moreover, cannot be overlooked the fact that as cells line C3A cytochrome 
metabolic activity can be compromised with respect to physiological level 
[109]
. 
Carrying on the functional marker analysis, albumin and urea release is 
surely one of the main functions of hepatocytes. 
Albumin concentration per cells was more than twice increased in CNSM 
with respect to SMSM in both static and dynamic, indicating that a great key 
role was carrying out by cell cross-talk rather than the dynamic condition 
(Fig.42). Urea analysis demonstrated the both main role of co-culture and 
dynamic culture. Higher urea release was found in the dynamic set up, 
where cell are more stimulated by flow; but even higher is the concentration 
per cells in CNSM then in SMSM (Fig. 43). 
These data confirmed the result obtained in the metabolism analysis, being 
also the marker of functionality closer to in vivo in the Cell Number Scaling 
Model. 
This study demonstrated as high importance has to be given to the 
advanced in vitro model in order to find relevant physiological condition. Not 
only cross-talk and physical stimulus played an import role within the in vitro 
model, but also the exact relationship between cells is crucial to recreate the 
regular state of in-vivo in which cells feel suitable and equilibrate signals.  
It has to be taken in account that most of the pathological state can be due 
to different relationship between cells numbers or signaling, like in 
hypertrophies or in several disease like Parkinson where less cells of the 
substantia nigra give failure in the signals lead to degenerative disorder. 
Working with random number of cells in a co-culture could give rise to 
pathological state model rather than physiological. 
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In this part it was demonstrated as allometry improved the dynamic 
connected culture and orientated the choice for a suitable model of intestinal 
tract. 
 
4. NP DYNAMIC TESTING WITH SINGLE TISSUE CONFIGURATION 
The next level in the development of advanced models was to go a step 
further in complexity. From NP assessment in standard static cultures, once 
dynamic parameters were set, it was possible to increase the complexity 
and the resemblance to the in vivo scenario by first assessing NP toxicity in 
dynamic conditions. 
Target tissues were tested separately under flow conditions and the most 
toxic nanomaterial, Ag NP was chosen as the first to be tested as significant 
toxic effects were expected. 
Interestingly Ag toxicity under flow conditions both for HUVEC and C3A 
(Fig. 44 and 48) was higher with respect to static conditions (Fig. 17 A), 
showing an LC50 of 12.1 µg/mL instead of 25 µg/cm2 for HUVEC and 
decreasing from 23 µg/cm2 [120] of the static culture to 12.4 µg/mL for C3A in 
dynamic conditions. High IL8 release was found in both HUVEC static and 
dynamic set up at the Ag concentration close to the LC50 value, while again 
low ICAM-1 concentration was measured in the dynamic samples, mirroring 
the static behavior. The apoptosis levels were comparable too, even though 
the IC50 values were different.  
Another interesting result was the vWF expression which was not 
significantly higher at low Ag concentration with respect to the control as 
observed for the static experiments. In order to understand this data it is 
important to underline that  vWF is also a marker of shear stress in HUVEC: 
higher expression of this factor under flow with respect to static conditions is 
well known in the literature [106], so the flow stimulated vWF expression can 
hide the stimulation due to the presence of the particles. 
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Analysing C3A inflammatory markers, the results under flow were 
comparable to the static data, showing an increase in the release, up to the 
IC50, after which it declined due to cytotoxicity [120].  
In conclusion in dynamic experiments Ag NP triggered all the effects 
observed in the static culture but at lower Ag concentrations, demonstrating 
the important role of the flow in effecting the cells response to molecules 
and particles.  
Physiologically no system is in a completely motionless state, cells are 
always subjected to some kind of dynamicity, from high vascular to 
interstitial flow.  
These data demonstrates that dynamic conditions are an important feature 
to take into account when assaying the effect of drugs or molecules. In this 
case a higher (the lethal dose was about half) toxicity of Ag NP was shown, 
pointing out the importance of physiological relevance and more closely 
approximating the in vivo situation when the aim of the work is to test 
toxicology and create a safety report for new materials. 
 
5. ILT COMPLETE SYSTEM BASELINE 
The three tissue model for absorption, distribution and metabolism should 
first be able to maintain cells in a healthy and functional state.  
With this aim the ILT complete system was tested to see whether is possible 
to distinguish between the healthy and highly toxic conditions. In these 
experiments the baseline control of healthy cells in the 3 tissues ILT system 
was referred to as "negative control", the static single cell culture was "static 
control" and the highly toxic conditions in the 3 tissues ILT was "positive ILT 
control".  
The negative control untreated cells showed that viability under flow 
conditions in the three tissue configuration was comparable to the static 
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control. No inflammation or apoptosis was found, while markers for 
functionality were expressed at high levels. 
In the positive ILT control (TRITON X) with dead cells, LDH from lower 
circuit was significantly (p<0.01) higher than baseline-negative control data 
in the 24 h (Fig. 54), while in the upper circuit the handling of CaCo-2 while 
assembling the system may have induced some stress on the cells but the 
difference between the static CaCo-2 control and the complete ILT system 
was insignificant (p=0.056). It was possible to ascribe this stress to the initial 
step of the experiment observing the 1 h data that was already quite high 
(Fig. 54 A). Anyway the low level of stress did not affect the function of the 
CaCo-2 as demonstrated by the TEER data in figure 57, chapter 6. 
Strangely a slight decrease in LDH content in the 24 h with respect to earlier 
sampling for the positive control experiment can be noted; this might 
indicate an LDH adsorption to the tubing or the bioreactor walls or a 
TRITON associated degradation of LDH (Fig. 55). 
Looking at the inflammation markers, the under detection limit data were 
expected both from baseline and TRITON-X samples. In fact, no 
inflammation should be present in the negative control, but neither is 
TRITON-X able to induce inflammation on cells.  
Results concerning ICAM-1 concentration in the upper circuit seems to be 
due more to flow stimulation on CaCo-2 cells in the negative control, since 
the concentration increased in time (Fig. 56 A), while a constant amount of 
ICAM-1 was found in the positive control (Fig. 56), this time due to an initial 
high release, finding comparable values during the 24 h. 
CaCo-2 function was demonstrated by the integrity of the cell layer: after a 
small period of adjustment in the resistance value, the trend was constant. 
Small variations in the measurement correspond to the sampling times (1 h, 
3 h, 8 h), during which the system had to be manipulated slightly to allow 
the sampling (Fig. 57). 
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The expression of stained markers in HUVEC and C3A was significantly 
(p<0.01) higher in the negative control than in the positive control (Fig. 58 
and 60). 
Further relevant data were provided by the albumin analysis. As expected 
for the negative controls, no albumin was detected in the upper circuit (no 
hepatocytes there) while a high concentration was found in the lower circuit 
where functional hepatocytes released high amount of albumin (Fig. 59). 
Comparable low values were found, instead, in both circuits in the positive 
control where dead cells were not able to release significant amount of 
albumin, but also where the open barrier of a dying intestinal epithelium 
allowed the passage of some albumin from the lower circuit (Fig. 59).  
This last result confirms the relevance of the ILT system: when an intact 
epithelial layer was present, barrier properties were shown, preventing even 
the passage of small molecules like albumin; when the barrier was 
compromised passage across the membrane was possible and basolateral 
molecules could be found in the CaCo-2 apical tract. 
This data clearly show that an advanced in vitro system able to reproduce 
barrier properties as in the intestinal tract was developed. The system is 
also able to recreate a multi-organ environment so as to have cross-talk 
between cells and an environment which is closer to the physiological in 
vivo milieu. 
 
6. NPs TESTING IN ILT SYSTEM 
Having demonstrated that the ILT system worked, it was possible to start 
NP testing with the ILT method. 
The last part of this thesis was addressed towards the evaluation of NP 
passage across the intact cell barrier.  
From previous studies it is known that NP passage through the ILT 
membrane without cells is around 10-15%. To perform this study it was 
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chosen to use the fluorescent PS-FITC NP either for the easiness of 
measuring high-fluorescence NP either thanks to the low toxicity of this 
particle which were shown not to affect the barrier cell viability.  
In fact, in order to reach detectable concentration in the lower circuit, there 
should be possible to use quite high concentration in the upper 
compartment, so low toxicity NP are required. 
Viability of cells in the PS-FITC NP experiment (Fig. 61) confirmed that 1 
mg/mL NP concentration was still not toxic for CaCo-2, while IL8 but not 
ICAM showed a high inflammation state of the target cell circuit (Fig. 62 A 
and B). Functionality of cells was comparable to control for CaCo-2 and 
C3A, while a small decrease in the vWF expression was found in the 
HUVEC cells (Fig. 63). 
Looking at the lower circuit fluorescence measurement seemed that nothing 
was able to pass through. A lower than 10% of passage (correspondent to 
passage without cells) was expected; but CaCo-2 tight layer decreased NP 
transport to less than 1% (fix as detection limit) of the upper circuit 
concentration.  
In order to understand if the value less than 1% meant that still some 
particles were able to translocate in a really low-undetectable concentration, 
fluorescent micrograph of target cells were taken using confocal analysis. 
The few particles (green dots in fig. 65 and 66) taken up by target cells in 
the lower circuit attested that PS-FITC NP was able to cross the barrier but 
in a less than 1% concentration. This data looks promising as low 
translocation (less than 0.4%) was already observed for nanoparticles in 
vivo [121]. 
Overall this concentration of particles cannot justify the modification in the 
marker concentration observed in the lower circuit.  
IL8 release was huge and neither with higher concentration of PS-FITC NP 
this level was reached.  
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For this reason it is plausible to postulate an effect due to the cross-talk 
between cells, where messengers released from one cell type (maybe 
CaCo-2) can start the inflammation cascade on other cells (i.e. Target cells). 
Both viability of HUVEC and C3A and albumin release were comparable to 
controls, moreover vWF expression was found increased with low 
concentration of NPs (Fig. 63), so this loss of function seemed not to be 
ascribed to PS-NP. 
Conversely, the preliminary data of Ag NP testing on cells were closer to the 
Ag NP sub-lethal effect induction.  
Viability drops down only for CaCo-2 (directly exposed cells) to 50% and 1% 
respectively with 50 µg/mL and 200 µg/mL Ag NP concentration, while 
target cells still showed a viable cell metabolic activity (Fig. 67). 
Inflammation, instead, reflected the Ag NP toxicity showing high IL8 release 
but no ICAM-1 at low concentration (Fig. 68 A and B respectively). The 
effect of high Ag concentration led to slight decrease in the target cell 
function (lower vWF expression, fig. 70 and lower albumin release, fig 71, 
chapter 6) highlighting a higher Ag NP concentration in the lower circuit, 
since particles were able to cross the inefficient barrier of dead CaCo-2. 
When the particle concentration reaches a toxic level, barrier properties are 
lost leading to higher amount of particle translocation. 
This study demonstrated the importance of barrier properties in the 
evaluation of molecule translocation across the intestinal epithelium. 
An intact and tight epithelial layer represents a sort of protection for the 
body, preventing the direct passage of toxicants.  
Anyway, as it happens in the multi-organ environment, consequences of 
direct stimulus on a cell type can be reflected on other organs even far away 
from the locus of action of the stimulus. Hence, direct effect of NPs on 
CaCo-2 cells can trigger inflammation on downstream cells that have no 
  
133 
 
direct exposure to the stimulus, but they can feel a perturbed state in the 
body-system so initiation of a concerted response from the whole body. 
The multiorgan response is an important feature to take in account that 
standard methods often neglects. Pharmacology literature teaches us that 
frequently drugs designed to have effect on an organ also interfere with 
other pathways triggering for example side effects on other organ (i.e. 
hepatic toxicity of Nimesulide [3]).  
The ILT system is an improved method that considers further levels involved 
in the response cascade. Moreover it integrates a biological barrier that 
usually is able to change the magnitude of a stimulus leading a more 
physiologically relevant situation. 
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Section IV 
Conclusion 
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Chapter 8 
Conclusion 
 
Physiologically relevant methods are the frontier of future in vitro research. 
This thesis is driven by the great interest that involves the development of 
new in vitro models able of investigating systemic and multiple pathway 
interactions. More convenient and ethically less questionable models 
capable of recapitulating inter-organ cross talk are particularly relevant in 
toxicology where the need of the complex response machinery of the body 
and the inadequacy of traditional in vitro methods have led to the massive 
use of the animal model. 
A variety of advanced models have been proposed to overcome the 
simplicity of current methods. Unfortunately, 3D cell culture models, tissue 
slices or micro-scale cell culture device have had difficulty in gaining 
widespread acceptance and usage both because new model needs to be 
tested and validated each time and because new protocols are required. For 
this reason, in the current project, a body-on-a-plate able to translate 
standard protocols and cell handling techniques with minimal adaptation 
rather a microfluidic body-on-a-chip device was designed. 
The principal goal of this thesis was to develop a new method to study on 
the effects of nanoparticles after ingestion using a 3 tissue connected 
culture system, the ILT.  
The ILT system development embraced different disciplines (biology, 
engineer, toxicology, drug delivery etc.) to reach a high level of complexity 
integrating an epithelial bio-barrier with a vascular-hepatic connected culture 
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in order to recapitulate the processes of absorption, distribution and 
metabolism in the human body. 
Firstly an allometric study demonstrated the key role of conserving cell 
proportions in the body when recreating the organ-system in vitro. This 
thesis showed different numbers of cells in a scaling relationship leads to 
different results due to differences cell-cell interaction mediated by soluble 
signals. 
To validate and compare the ILT system with conventional techniques, a 
toxicological study on cells with both standard methods and advanced ones 
was performed. The results from this study were used to analyze and 
understand data from the new more complex models in order to gain new 
insights into NP toxicity at different levels. 
In the study with conventional methods (static multiwell plate) a range of 
engineered nanoparticles of industrial interest was tested assaying various 
levels of toxicity, from sub-lethal to fatal levels. 
It was shown that not only cell viability could be affected but also 
inflammation or function impairment could also be triggered. Silver NPs are 
found to be highly toxic even at low concentrations and surprisingly TiO2 
NPs also showed high toxicity on HUVEC cells while the literature describes 
it to be non-toxic on other cell cultures. 
Furthermore, this thesis confirms the dependency of nanotoxicity on the size 
(Au 15 and Au 80 nm) and the type of NP (Ag, TiO2, Au, PS NP). 
Concrete evidence of how significant the use of an improved method is, 
comes out with studying NP toxicity within dynamic conditions: Ag NP was 
found to be twice as toxic under flow conditions, underlining the different 
behavior of cells and of their interaction with NP in the two models.  
The dynamic conditions are closer to the in vivo environment as no 
physiological system is static: flow, movement and concentration gradients 
are present in all animals. 
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Another insight gained in this thesis was the central role of biological 
barriers. Comparison of the nanoparticle passage data in the two flow ILT 
system with the in vivo literature result showed a promising correlation 
between the NP translocation percentages across the intestinal epithelium. 
Bio barriers are fundamental to address the right dose that actually reaches 
the systemic circulation, so avoiding the testing of non-relevant doses. 
In conclusion, in this thesis a new body-on-a-plate device (ILT) in which 
culture chambers are connected by the flow of a common medium was 
developed, tested and validated.  
Data demonstrated that ILT system device is able to simulate an in vivo-like 
environment and to mimic ligand mediated cross-talk between different cells 
connected by the blood stream as occurs in the body.  
The new method was tested assaying NP toxicity, but it could be used with 
a large range of molecules of industrial and scientific interest (drugs, toxics, 
proteins, antibodies) and even to study in-vivo targeting, molecular 
mechanisms and physiological and pathological interactions between 
organs. 
This work will have a high impact on the advancement of in vitro models and 
the ILT system developed has been patented in order to continue the R&D 
on a large scale.  
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Glossary 
ACRONYM SIGNIFICATION 
NP Nanoparticle 
Ag NP Silver Nanoparticle 
PS NP Polystyrene-FITC Nanoparticle 
Au NP Gold Nanoparticles 
TiO2 NP Titanium dioxide Nanoparticles 
HUVEC Human umbilical vein endothelial cells 
C3A Immortalized human hepatoma cell line 
CaCo-2 Human epithelial colorectal adenocarcinoma cell line 
ILT 0 Target tissues bioreactor 
ILT 2  Intestinal cell bioreactor 
ILT system New connected three tissues dynamic culture 
SMSM Surface and Metabolic Scaling Model  
CNSM Cell Number Scaling Model 
LDH Lactate dehydrogenase 
GSH Glutathione (γ-L-glutammil-L-cisteinilglicina) 
GSSG Glutathione disulfide 
ICAM-1 Inter-Cellular Adhesion Molecule 1 
IL 8 Interleukin 8  
vWF Von Willebrand factor 
TNF-α Tumor Necrosis Factor-α 
Fas-L Fas-Ligand or CD95L 
CYP450 Cytochrome P 450  
FFA Free Fatty Acid 
TRITON-X 100 C14H22O(C2H4O)n)  a non-ionic surfactant 
LC50 Half lethal concentration 
TEER Trans epithelial electrical resistance 
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ELISA Enzyme-linked immunosorbent assay 
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